WELL 10-Q Quarterly Report June 30, 2020 | Alphaminr

WELL 10-Q Quarter ended June 30, 2020

WELLTOWER INC.
10-Ks and 10-Qs
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
well-20200630
0000766704 false 2020 Q2 December 31 P1Y well:LeaseRightOfUseAsset well:LeaseRightOfUseAsset well:LeaseRightOfUseAsset well:LeaseRightOfUseAsset well:LeaseLiability well:LeaseLiability well:LeaseLiability well:LeaseLiability us-gaap:AccountingStandardsUpdate201613Member P3Y 0000766704 2020-01-01 2020-06-30 0000766704 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0000766704 well:NotesDue20284.800Member 2020-01-01 2020-06-30 0000766704 well:NotesDue20344.500Member 2020-01-01 2020-06-30 xbrli:shares 0000766704 2020-07-31 iso4217:USD 0000766704 2020-06-30 0000766704 2019-12-31 0000766704 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-06-30 0000766704 us-gaap:ManagementServiceMember 2020-04-01 2020-06-30 0000766704 us-gaap:ManagementServiceMember 2019-04-01 2019-06-30 0000766704 us-gaap:ManagementServiceMember 2020-01-01 2020-06-30 0000766704 us-gaap:ManagementServiceMember 2019-01-01 2019-06-30 0000766704 2020-04-01 2020-06-30 0000766704 2019-04-01 2019-06-30 0000766704 2019-01-01 2019-06-30 0000766704 well:InterestRevenueMember 2020-04-01 2020-06-30 0000766704 well:InterestRevenueMember 2019-04-01 2019-06-30 0000766704 well:InterestRevenueMember 2020-01-01 2020-06-30 0000766704 well:InterestRevenueMember 2019-01-01 2019-06-30 0000766704 us-gaap:ProductAndServiceOtherMember 2020-04-01 2020-06-30 0000766704 us-gaap:ProductAndServiceOtherMember 2019-04-01 2019-06-30 0000766704 us-gaap:ProductAndServiceOtherMember 2020-01-01 2020-06-30 0000766704 us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-06-30 iso4217:USD xbrli:shares 0000766704 us-gaap:CommonStockMember 2019-12-31 0000766704 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000766704 us-gaap:TreasuryStockMember 2019-12-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2019-12-31 0000766704 well:AccumulatedDistributionsMember 2019-12-31 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-12-31 0000766704 us-gaap:NoncontrollingInterestMember 2019-12-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000766704 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2019-12-31 0000766704 us-gaap:CommonStockMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000766704 us-gaap:AdditionalPaidInCapitalMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000766704 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:TreasuryStockMember 2019-12-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000766704 well:AccumulatedDistributionsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000766704 us-gaap:NoncontrollingInterestMember srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000766704 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2019-12-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2020-01-01 2020-03-31 0000766704 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000766704 2020-01-01 2020-03-31 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000766704 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000766704 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000766704 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0000766704 well:AccumulatedDistributionsMember 2020-01-01 2020-03-31 0000766704 us-gaap:CommonStockMember 2020-03-31 0000766704 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000766704 us-gaap:TreasuryStockMember 2020-03-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2020-03-31 0000766704 well:AccumulatedDistributionsMember 2020-03-31 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-03-31 0000766704 us-gaap:NoncontrollingInterestMember 2020-03-31 0000766704 2020-03-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2020-04-01 2020-06-30 0000766704 us-gaap:NoncontrollingInterestMember 2020-04-01 2020-06-30 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0000766704 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0000766704 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0000766704 us-gaap:TreasuryStockMember 2020-04-01 2020-06-30 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-04-01 2020-06-30 0000766704 well:AccumulatedDistributionsMember 2020-04-01 2020-06-30 0000766704 us-gaap:CommonStockMember 2020-06-30 0000766704 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0000766704 us-gaap:TreasuryStockMember 2020-06-30 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2020-06-30 0000766704 well:AccumulatedDistributionsMember 2020-06-30 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2020-06-30 0000766704 us-gaap:NoncontrollingInterestMember 2020-06-30 0000766704 us-gaap:PreferredStockMember 2018-12-31 0000766704 us-gaap:CommonStockMember 2018-12-31 0000766704 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000766704 us-gaap:TreasuryStockMember 2018-12-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2018-12-31 0000766704 well:AccumulatedDistributionsMember 2018-12-31 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2018-12-31 0000766704 us-gaap:NoncontrollingInterestMember 2018-12-31 0000766704 2018-12-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2019-01-01 2019-03-31 0000766704 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0000766704 2019-01-01 2019-03-31 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000766704 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000766704 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000766704 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-01-01 2019-03-31 0000766704 us-gaap:PreferredStockMember 2019-01-01 2019-03-31 0000766704 well:AccumulatedDistributionsMember 2019-01-01 2019-03-31 0000766704 us-gaap:PreferredStockMember 2019-03-31 0000766704 us-gaap:CommonStockMember 2019-03-31 0000766704 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000766704 us-gaap:TreasuryStockMember 2019-03-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2019-03-31 0000766704 well:AccumulatedDistributionsMember 2019-03-31 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-03-31 0000766704 us-gaap:NoncontrollingInterestMember 2019-03-31 0000766704 2019-03-31 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2019-04-01 2019-06-30 0000766704 us-gaap:NoncontrollingInterestMember 2019-04-01 2019-06-30 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000766704 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000766704 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000766704 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-04-01 2019-06-30 0000766704 well:AccumulatedDistributionsMember 2019-04-01 2019-06-30 0000766704 us-gaap:PreferredStockMember 2019-06-30 0000766704 us-gaap:CommonStockMember 2019-06-30 0000766704 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000766704 us-gaap:TreasuryStockMember 2019-06-30 0000766704 us-gaap:RetainedEarningsUnappropriatedMember 2019-06-30 0000766704 well:AccumulatedDistributionsMember 2019-06-30 0000766704 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000766704 us-gaap:DeferredCompensationShareBasedPaymentsMember 2019-06-30 0000766704 us-gaap:NoncontrollingInterestMember 2019-06-30 0000766704 2019-06-30 xbrli:pure 0000766704 well:SeniorHousingOperatingMember well:COVID19Member 2020-02-29 0000766704 well:SeniorHousingOperatingMember well:COVID19Member 2020-03-31 0000766704 well:SeniorHousingOperatingMember well:COVID19Member 2020-04-30 0000766704 well:SeniorHousingOperatingMember well:COVID19Member 2020-05-31 0000766704 well:SeniorHousingOperatingMember well:COVID19Member 2020-06-30 0000766704 well:SeniorHousingOperatingMember well:COVID19Member us-gaap:SubsequentEventMember 2020-07-31 0000766704 well:COVID19Member 2020-04-01 2020-06-30 0000766704 well:COVID19Member 2020-01-01 2020-06-30 0000766704 well:COVID19Member us-gaap:SubsequentEventMember 2020-07-01 2020-07-31 0000766704 well:COVID19Member us-gaap:SubsequentEventMember 2020-06-01 2020-07-31 0000766704 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2019-12-31 0000766704 well:SeniorHousingOperatingMember 2020-06-30 0000766704 well:TripleNetMember 2020-06-30 0000766704 well:OutpatientMedicalMember 2020-06-30 0000766704 well:SeniorHousingOperatingMember 2019-06-30 0000766704 well:TripleNetMember 2019-06-30 0000766704 well:OutpatientMedicalMember 2019-06-30 0000766704 well:SeniorHousingOperatingMember 2020-01-01 2020-06-30 0000766704 well:TripleNetMember 2020-01-01 2020-06-30 0000766704 well:OutpatientMedicalMember 2020-01-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember 2019-01-01 2019-06-30 0000766704 well:TripleNetMember 2019-01-01 2019-06-30 0000766704 well:OutpatientMedicalMember 2019-01-01 2019-06-30 0000766704 us-gaap:LeasesAcquiredInPlaceMember 2020-06-30 0000766704 us-gaap:LeasesAcquiredInPlaceMember 2019-12-31 0000766704 us-gaap:AboveMarketLeasesMember 2020-06-30 0000766704 us-gaap:AboveMarketLeasesMember 2019-12-31 0000766704 well:LeaseCommissionsMember 2020-06-30 0000766704 well:LeaseCommissionsMember 2019-12-31 0000766704 2019-01-01 2019-12-31 well:property 0000766704 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2020-06-30 0000766704 us-gaap:SubsequentEventMember 2020-07-01 2020-08-06 well:properties 0000766704 well:SeniorHousingOperatingMember 2020-04-01 2020-06-30 0000766704 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2020-01-01 2020-03-31 0000766704 well:SeniorHousingOperatingMember us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2020-06-30 0000766704 us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember 2020-04-01 2020-06-30 0000766704 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2020-04-01 2020-06-30 0000766704 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2019-04-01 2019-06-30 0000766704 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2020-01-01 2020-06-30 0000766704 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember 2019-01-01 2019-06-30 0000766704 srt:MinimumMember 2020-01-01 2020-06-30 0000766704 srt:MaximumMember 2020-01-01 2020-06-30 0000766704 us-gaap:CostOfSalesMember 2020-01-01 2020-06-30 0000766704 us-gaap:CostOfSalesMember 2019-01-01 2019-06-30 0000766704 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-06-30 0000766704 us-gaap:GeneralAndAdministrativeExpenseMember 2019-01-01 2019-06-30 0000766704 us-gaap:OperatingSegmentsMember 2020-06-30 0000766704 us-gaap:OperatingSegmentsMember 2019-12-31 0000766704 us-gaap:CorporateNonSegmentMember 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember 2019-12-31 0000766704 well:OperatingSegmentsAndCorporateNonSegmentMember 2020-06-30 0000766704 well:OperatingSegmentsAndCorporateNonSegmentMember 2019-12-31 0000766704 us-gaap:MortgageReceivablesMember 2020-06-30 0000766704 us-gaap:MortgageReceivablesMember 2019-12-31 0000766704 well:OtherRealEstateLoansReceivablesMember 2020-06-30 0000766704 well:OtherRealEstateLoansReceivablesMember 2019-12-31 0000766704 us-gaap:RealEstateLoanMember 2020-06-30 0000766704 us-gaap:RealEstateLoanMember 2019-12-31 0000766704 well:NonRealEstateLoansReceivablesMember 2020-06-30 0000766704 well:DeterioratedLoansMember 2020-06-30 well:loan 0000766704 well:CollectiveLoanPool1Member 2020-06-30 0000766704 well:CollectiveLoanPool2Member 2020-06-30 0000766704 well:CollectiveLoanPool3Member 2020-06-30 0000766704 well:CollectiveLoanPool4Member 2020-06-30 0000766704 well:CollectiveLoanPool5Member 2020-06-30 0000766704 us-gaap:AccountsPayableAndAccruedLiabilitiesMember 2020-01-01 2020-06-30 0000766704 2019-03-01 2019-03-31 0000766704 well:NonRealEstateLoansReceivablesMember 2020-01-01 2020-06-30 0000766704 well:RealEstateLoanReceivableMember 2020-01-01 2020-06-30 0000766704 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2018-12-31 0000766704 srt:MinimumMember well:SeniorsHousingOperatingMember 2020-06-30 0000766704 well:SeniorsHousingOperatingMember srt:MaximumMember 2020-06-30 0000766704 well:SeniorsHousingOperatingMember 2020-06-30 0000766704 well:SeniorsHousingOperatingMember 2019-12-31 0000766704 srt:MinimumMember well:TripleNetMember 2020-06-30 0000766704 well:TripleNetMember srt:MaximumMember 2020-06-30 0000766704 well:TripleNetMember 2020-06-30 0000766704 well:TripleNetMember 2019-12-31 0000766704 srt:MinimumMember well:OutpatientMedicalMember 2020-06-30 0000766704 well:OutpatientMedicalMember srt:MaximumMember 2020-06-30 0000766704 well:OutpatientMedicalMember 2020-06-30 0000766704 well:OutpatientMedicalMember 2019-12-31 0000766704 us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:SunriseMember 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:SunriseMember 2020-01-01 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:ProMedicaMember 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:ProMedicaMember 2020-01-01 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:GenesisHealthCareCorporationMember 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:GenesisHealthCareCorporationMember 2020-01-01 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:ReveraMember 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:ReveraMember 2020-01-01 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:AveryHealthcareMember 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:AveryHealthcareMember 2020-01-01 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:RemainingPortfolioMember 2020-06-30 0000766704 well:NetOperatingingIncomeMember well:RemainingPortfolioMember 2020-01-01 2020-06-30 0000766704 well:NetOperatingingIncomeMember 2020-06-30 0000766704 well:NetOperatingingIncomeMember 2020-01-01 2020-06-30 well:bank 0000766704 us-gaap:RevolvingCreditFacilityMember 2020-06-30 0000766704 well:TermCreditFacilityMember 2020-06-30 0000766704 well:TermCreditFacilityCADDenominatedMember 2020-06-30 0000766704 well:AccordionfeaturememberMember 2020-06-30 0000766704 well:TermCreditFacilityCADDenominatedMember well:AccordionfeaturememberMember 2020-06-30 0000766704 us-gaap:LondonInterbankOfferedRateLIBORMember 2020-01-01 2020-06-30 well:term 0000766704 us-gaap:RevolvingCreditFacilityMember 2020-01-01 2020-06-30 0000766704 us-gaap:CommercialPaperMember srt:MaximumMember 2019-01-01 2019-01-31 0000766704 us-gaap:CommercialPaperMember 2019-01-31 0000766704 us-gaap:UnsecuredDebtMember 2020-06-30 0000766704 us-gaap:SecuredDebtMember 2020-06-30 0000766704 srt:MinimumMember us-gaap:UnsecuredDebtMember 2020-06-30 0000766704 us-gaap:UnsecuredDebtMember srt:MaximumMember 2020-06-30 0000766704 srt:MinimumMember us-gaap:SecuredDebtMember 2020-06-30 0000766704 us-gaap:SecuredDebtMember srt:MaximumMember 2020-06-30 0000766704 well:UnsecuredTermCreditFacilityDueApril2022Member us-gaap:UnsecuredDebtMember 2020-06-30 0000766704 well:UnsecuredTermCreditFacilityDueApril2022Member us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:UnsecuredDebtMember 2020-01-01 2020-06-30 0000766704 well:UnsecuredTermCreditFacilityDueApril2022Member us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:UnsecuredDebtMember 2020-06-30 iso4217:CAD 0000766704 well:TermLoanMember us-gaap:UnsecuredDebtMember 2020-06-30 0000766704 well:CanadianDealerOfferedRateMember well:TermLoanMember us-gaap:UnsecuredDebtMember 2020-01-01 2020-06-30 0000766704 well:CanadianDealerOfferedRateMember well:TermLoanMember us-gaap:UnsecuredDebtMember 2020-06-30 0000766704 well:UnsecuredTermCreditFacilityMaturesJuly192023Member us-gaap:UnsecuredDebtMember 2020-06-30 0000766704 well:UnsecuredTermCreditFacilityMaturesJuly192023Member us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:UnsecuredDebtMember 2020-01-01 2020-06-30 0000766704 well:UnsecuredTermCreditFacilityMaturesJuly192023Member us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:UnsecuredDebtMember 2020-06-30 0000766704 well:A295SeniorUnsecuredNotesDue2023Member us-gaap:UnsecuredDebtMember 2020-06-30 iso4217:GBP 0000766704 us-gaap:UnsecuredDebtMember well:UkDebtDue2028Member 2020-06-30 0000766704 us-gaap:UnsecuredDebtMember well:A450SeniorUnsecuredNotesDue2034Member 2020-06-30 0000766704 us-gaap:UnsecuredDebtMember 2019-12-31 0000766704 us-gaap:UnsecuredDebtMember 2018-12-31 0000766704 us-gaap:UnsecuredDebtMember 2020-01-01 2020-06-30 0000766704 us-gaap:UnsecuredDebtMember 2019-01-01 2019-06-30 0000766704 us-gaap:UnsecuredDebtMember 2019-06-30 0000766704 well:TermCreditFacilityMember us-gaap:UnsecuredDebtMember 2020-04-30 0000766704 well:TermCreditFacilityMember us-gaap:UnsecuredDebtMember 2020-04-01 2020-04-30 0000766704 well:TermCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember us-gaap:UnsecuredDebtMember 2020-04-01 2020-04-30 0000766704 well:A275SeniorUnsecuredNotesMember us-gaap:UnsecuredDebtMember 2020-06-30 0000766704 well:A275SeniorUnsecuredNotesMember us-gaap:UnsecuredDebtMember 2020-04-30 0000766704 well:A375SeniorUnsecuredNotesMember us-gaap:UnsecuredDebtMember us-gaap:SubsequentEventMember 2020-07-01 2020-07-01 0000766704 well:A375SeniorUnsecuredNotesMember us-gaap:UnsecuredDebtMember us-gaap:SubsequentEventMember 2020-07-01 0000766704 well:A395SeniorUnsecuredNotesMember us-gaap:UnsecuredDebtMember us-gaap:SubsequentEventMember 2020-07-01 2020-07-01 0000766704 well:A395SeniorUnsecuredNotesMember us-gaap:UnsecuredDebtMember us-gaap:SubsequentEventMember 2020-07-01 0000766704 us-gaap:SubsequentEventMember 2020-07-01 2020-07-01 0000766704 well:TermCreditFacilityMember us-gaap:UnsecuredDebtMember us-gaap:SubsequentEventMember 2020-07-02 2020-07-02 0000766704 us-gaap:SecuredDebtMember 2019-12-31 0000766704 us-gaap:SecuredDebtMember 2018-12-31 0000766704 us-gaap:SecuredDebtMember 2020-01-01 2020-06-30 0000766704 us-gaap:SecuredDebtMember 2019-01-01 2019-06-30 0000766704 us-gaap:SecuredDebtMember 2019-06-30 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember currency:CAD us-gaap:NetInvestmentHedgingMember 2020-06-30 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember currency:CAD us-gaap:NetInvestmentHedgingMember 2019-12-31 0000766704 currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2020-06-30 0000766704 currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2019-12-31 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember currency:CAD us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-06-30 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember currency:CAD us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-12-31 0000766704 currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2020-01-01 2020-06-30 0000766704 currency:GBP us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:NetInvestmentHedgingMember 2019-01-01 2019-12-31 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember currency:USD us-gaap:CashFlowHedgingMember 2020-06-30 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember currency:USD us-gaap:CashFlowHedgingMember 2019-12-31 0000766704 us-gaap:NondesignatedMember currency:USD 2020-06-30 0000766704 us-gaap:NondesignatedMember currency:USD 2019-12-31 0000766704 us-gaap:NondesignatedMember us-gaap:ShortMember currency:CAD 2020-06-30 0000766704 us-gaap:NondesignatedMember us-gaap:ShortMember currency:CAD 2019-12-31 0000766704 us-gaap:NondesignatedMember currency:GBP us-gaap:LongMember 2020-06-30 0000766704 us-gaap:NondesignatedMember currency:GBP us-gaap:LongMember 2019-12-31 0000766704 us-gaap:NondesignatedMember currency:GBP us-gaap:ShortMember 2020-06-30 0000766704 us-gaap:NondesignatedMember currency:GBP us-gaap:ShortMember 2019-12-31 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember 2020-04-01 2020-06-30 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember 2019-04-01 2019-06-30 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-06-30 0000766704 us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-06-30 0000766704 us-gaap:NondesignatedMember 2020-04-01 2020-06-30 0000766704 us-gaap:NondesignatedMember 2019-04-01 2019-06-30 0000766704 us-gaap:NondesignatedMember 2020-01-01 2020-06-30 0000766704 us-gaap:NondesignatedMember 2019-01-01 2019-06-30 0000766704 us-gaap:ForeignExchangeContractMember 2019-04-01 2019-06-30 0000766704 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-06-30 well:obligation 0000766704 2018-01-01 2018-12-31 0000766704 well:EquityShelfProgramMember 2019-01-01 2019-06-30 0000766704 well:EquityShelfProgramMember 2019-02-28 0000766704 well:EquityShelfProgramMember 2020-06-30 0000766704 well:RepurchaseProgramMember 2020-05-01 0000766704 well:RepurchaseProgramMember 2020-01-01 2020-06-30 0000766704 well:RepurchaseProgramMember 2020-06-30 0000766704 us-gaap:AccumulatedTranslationAdjustmentMember 2020-06-30 0000766704 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000766704 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-06-30 0000766704 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000766704 us-gaap:MortgagesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-06-30 0000766704 us-gaap:MortgagesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-06-30 0000766704 us-gaap:MortgagesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000766704 us-gaap:MortgagesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000766704 well:OtherRealEstateLoansReceivableMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-06-30 0000766704 well:OtherRealEstateLoansReceivableMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-06-30 0000766704 well:OtherRealEstateLoansReceivableMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000766704 well:OtherRealEstateLoansReceivableMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000766704 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-06-30 0000766704 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000766704 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000766704 well:NonRealEstateLoansReceivablesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-06-30 0000766704 well:NonRealEstateLoansReceivablesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-06-30 0000766704 well:NonRealEstateLoansReceivablesMember us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000766704 well:NonRealEstateLoansReceivablesMember us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000766704 us-gaap:FairValueInputsLevel1Member 2020-06-30 0000766704 us-gaap:FairValueInputsLevel2Member 2020-06-30 0000766704 us-gaap:FairValueInputsLevel3Member 2020-06-30 well:segment 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2020-04-01 2020-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2020-04-01 2020-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2020-04-01 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember us-gaap:ManagementServiceMember 2020-04-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember 2020-04-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 well:TripleNetMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 well:OutpatientMedicalMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember well:InterestRevenueMember 2020-04-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 well:TripleNetMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 well:OutpatientMedicalMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2020-04-01 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember us-gaap:ProductAndServiceOtherMember 2020-04-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember 2020-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember 2020-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember 2020-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2019-04-01 2019-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2019-04-01 2019-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2019-04-01 2019-06-30 0000766704 us-gaap:CorporateNonSegmentMember us-gaap:ManagementServiceMember 2019-04-01 2019-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 us-gaap:CorporateNonSegmentMember 2019-04-01 2019-06-30 0000766704 well:SeniorHousingOperatingMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 well:TripleNetMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 well:OutpatientMedicalMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 us-gaap:CorporateNonSegmentMember well:InterestRevenueMember 2019-04-01 2019-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 well:TripleNetMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 well:OutpatientMedicalMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2019-04-01 2019-06-30 0000766704 us-gaap:CorporateNonSegmentMember us-gaap:ProductAndServiceOtherMember 2019-04-01 2019-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2020-01-01 2020-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2020-01-01 2020-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2020-01-01 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember us-gaap:ManagementServiceMember 2020-01-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 well:TripleNetMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 well:OutpatientMedicalMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember well:InterestRevenueMember 2020-01-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 well:TripleNetMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 well:OutpatientMedicalMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2020-01-01 2020-06-30 0000766704 us-gaap:CorporateNonSegmentMember us-gaap:ProductAndServiceOtherMember 2020-01-01 2020-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2019-01-01 2019-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2019-01-01 2019-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember us-gaap:ManagementServiceMember 2019-01-01 2019-06-30 0000766704 us-gaap:CorporateNonSegmentMember us-gaap:ManagementServiceMember 2019-01-01 2019-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 well:TripleNetMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 well:OutpatientMedicalMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-06-30 0000766704 well:SeniorHousingOperatingMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 well:TripleNetMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 well:OutpatientMedicalMember well:InterestRevenueMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 us-gaap:CorporateNonSegmentMember well:InterestRevenueMember 2019-01-01 2019-06-30 0000766704 well:SeniorHousingOperatingMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 well:TripleNetMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 well:OutpatientMedicalMember us-gaap:ProductAndServiceOtherMember us-gaap:OperatingSegmentsMember 2019-01-01 2019-06-30 0000766704 us-gaap:CorporateNonSegmentMember us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-06-30 0000766704 country:US 2020-04-01 2020-06-30 0000766704 country:US us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0000766704 country:US 2019-04-01 2019-06-30 0000766704 country:US us-gaap:SalesRevenueNetMember 2019-04-01 2019-06-30 0000766704 country:US 2020-01-01 2020-06-30 0000766704 country:US us-gaap:SalesRevenueNetMember 2020-01-01 2020-06-30 0000766704 country:US 2019-01-01 2019-06-30 0000766704 country:US us-gaap:SalesRevenueNetMember 2019-01-01 2019-06-30 0000766704 country:GB 2020-04-01 2020-06-30 0000766704 country:GB us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0000766704 country:GB 2019-04-01 2019-06-30 0000766704 country:GB us-gaap:SalesRevenueNetMember 2019-04-01 2019-06-30 0000766704 country:GB 2020-01-01 2020-06-30 0000766704 country:GB us-gaap:SalesRevenueNetMember 2020-01-01 2020-06-30 0000766704 country:GB 2019-01-01 2019-06-30 0000766704 country:GB us-gaap:SalesRevenueNetMember 2019-01-01 2019-06-30 0000766704 country:CA 2020-04-01 2020-06-30 0000766704 country:CA us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0000766704 country:CA 2019-04-01 2019-06-30 0000766704 country:CA us-gaap:SalesRevenueNetMember 2019-04-01 2019-06-30 0000766704 country:CA 2020-01-01 2020-06-30 0000766704 country:CA us-gaap:SalesRevenueNetMember 2020-01-01 2020-06-30 0000766704 country:CA 2019-01-01 2019-06-30 0000766704 country:CA us-gaap:SalesRevenueNetMember 2019-01-01 2019-06-30 0000766704 us-gaap:SalesRevenueNetMember 2020-04-01 2020-06-30 0000766704 us-gaap:SalesRevenueNetMember 2019-04-01 2019-06-30 0000766704 us-gaap:SalesRevenueNetMember 2020-01-01 2020-06-30 0000766704 us-gaap:SalesRevenueNetMember 2019-01-01 2019-06-30 0000766704 country:US 2020-06-30 0000766704 country:US us-gaap:AssetsTotalMember 2020-01-01 2020-06-30 0000766704 country:US 2019-12-31 0000766704 country:US us-gaap:AssetsTotalMember 2019-01-01 2019-12-31 0000766704 country:GB 2020-06-30 0000766704 country:GB us-gaap:AssetsTotalMember 2020-01-01 2020-06-30 0000766704 country:GB 2019-12-31 0000766704 country:GB us-gaap:AssetsTotalMember 2019-01-01 2019-12-31 0000766704 country:CA 2020-06-30 0000766704 country:CA us-gaap:AssetsTotalMember 2020-01-01 2020-06-30 0000766704 country:CA 2019-12-31 0000766704 country:CA us-gaap:AssetsTotalMember 2019-01-01 2019-12-31 0000766704 us-gaap:AssetsTotalMember 2020-01-01 2020-06-30 0000766704 us-gaap:AssetsTotalMember 2019-01-01 2019-12-31 0000766704 country:US us-gaap:SalesRevenueNetMember us-gaap:ManagementServiceMember 2020-04-01 2020-06-30 0000766704 country:GB us-gaap:SalesRevenueNetMember us-gaap:ManagementServiceMember 2020-04-01 2020-06-30 0000766704 country:CA us-gaap:SalesRevenueNetMember us-gaap:ManagementServiceMember 2020-04-01 2020-06-30 0000766704 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2020-06-30 0000766704 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2020
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 1-8923
WELLTOWER INC.
(Exact name of registrant as specified in its charter )
Delaware 34-1096634
(State or other jurisdiction
of Incorporation)
(IRS Employer
Identification No.)
4500 Dorr Street Toledo, Ohio 43615
(Address of principal executive offices) (Zip Code)
(419) 247-2800
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common stock, $1.00 par value per share WELL New York Stock Exchange
4.800% Notes due 2028 WELL28 New York Stock Exchange
4.500% Notes due 2034 WELL34 New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
þ
Accelerated filer
¨
Non-accelerated filer
¨
Smaller reporting company
Emerging growth company
(Do not check if a smaller reporting company)
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No þ
As of July 31, 2020, the registrant had 417,300,700 share s of common stock outstanding.



TABLE OF CONTENTS
Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets
Consolidated Statements of Comprehensive Income
Consolidated Statements of Equity
Consolidated Statements of Cash Flows
Notes to Unaudited Consolidated Financial Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 5. Other Information
Item 6. Exhibits
Signatures



PART I. FINANCIAL INFORMATION
Item 1. Financial Statements

CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
June 30, 2020 (Unaudited) December 31, 2019 (Note)
Assets:
Real estate investments:
Real property owned:
Land and land improvements
$ 3,479,369 $ 3,486,620
Buildings and improvements
28,589,269 29,163,305
Acquired lease intangibles
1,565,978 1,617,051
Real property held for sale, net of accumulated depreciation
382,580 1,253,008
Construction in progress
411,700 507,931
Less accumulated depreciation and amortization
( 6,001,177 ) ( 5,715,459 )
Net real property owned
28,427,719 30,312,456
Right of use assets, net 502,604 536,433
Real estate loans receivable, net of credit allowance 224,871 270,382
Net real estate investments 29,155,194 31,119,271
Other assets:
Investments in unconsolidated entities
786,921 583,423
Goodwill
68,321 68,321
Cash and cash equivalents
1,678,770 284,917
Restricted cash
147,473 100,849
Straight-line rent receivable
464,716 466,222
Receivables and other assets
861,257 757,748
Total other assets
4,007,458 2,261,480
Total assets
$ 33,162,652 $ 33,380,751
Liabilities and equity
Liabilities:
Unsecured credit facility and commercial paper
$ $ 1,587,597
Senior unsecured notes
11,815,972 10,336,513
Secured debt
2,619,678 2,990,962
Lease liabilities
447,424 473,693
Accrued expenses and other liabilities
1,015,906 1,009,482
Total liabilities
15,898,980 16,398,247
Redeemable noncontrolling interests
327,145 475,877
Equity:
Common stock
418,343 411,005
Capital in excess of par value
20,836,545 20,190,107
Treasury stock
( 93,799 ) ( 78,955 )
Cumulative net income
7,838,284 7,353,966
Cumulative dividends
( 12,834,381 ) ( 12,223,534 )
Accumulated other comprehensive income (loss)
( 116,856 ) ( 112,157 )
Other equity
4 12
Total Welltower Inc. stockholders’ equity
16,048,140 15,540,444
Noncontrolling interests
888,387 966,183
Total equity
16,936,527 16,506,627
Total liabilities and equity
$ 33,162,652 $ 33,380,751
Note: The consolidated balance sheet at December 31, 2019 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

3


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data)
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Revenues:
Resident fees and services
$ 769,560 $ 914,085 $ 1,619,532 $ 1,782,370
Rental income
396,305 385,586 786,265 766,670
Interest income
16,069 17,356 31,310 32,475
Other income
6,541 3,079 9,970 10,836
Total revenues
1,188,475 1,320,106 2,447,077 2,592,351
Expenses:
Property operating expenses
660,764 701,127 1,342,545 1,371,934
Depreciation and amortization
265,371 248,052 540,172 491,984
Interest expense
126,357 141,336 268,364 286,568
General and administrative expenses
34,062 33,741 69,543 69,023
Loss (gain) on derivatives and financial instruments, net
1,434 1,913 9,085 ( 574 )
Loss (gain) on extinguishment of debt, net
249 249 15,719
Provision for loan losses
1,422 8,494 18,690
Impairment of assets
75,151 9,939 102,978 9,939
Other expenses
19,411 21,628 25,703 30,384
Total expenses
1,184,221 1,157,736 2,367,133 2,293,667
Income (loss) from continuing operations before income taxes and other items 4,254 162,370 79,944 298,684
Income tax (expense) benefit ( 2,233 ) ( 1,599 ) ( 7,675 ) ( 3,821 )
Income (loss) from unconsolidated entities 1,332 ( 9,049 ) ( 2,360 ) ( 18,248 )
Gain (loss) on real estate dispositions, net 155,863 ( 1,682 ) 418,687 165,727
Income (loss) from continuing operations 159,216 150,040 488,596 442,342
Net income 159,216 150,040 488,596 442,342
Less: Net income (loss) attributable to noncontrolling interests (1)
( 20,030 ) 12,278 ( 934 ) 24,110
Net income (loss) attributable to common stockholders $ 179,246 $ 137,762 $ 489,530 $ 418,232
Average number of common shares outstanding:
Basic
417,084 404,607 413,696 398,073
Diluted
419,121 406,673 415,775 400,096
Earnings per share:
Basic:
Income (loss) from continuing operations
$ 0.38 $ 0.37 $ 1.18 $ 1.11
Net income (loss) attributable to common stockholders
$ 0.43 $ 0.34 $ 1.18 $ 1.05
Diluted:
Income (loss) from continuing operations
$ 0.38 $ 0.37 $ 1.18 $ 1.11
Net income (loss) attributable to common stockholders (2)
$ 0.42 $ 0.34 $ 1.17 $ 1.05
Dividends declared and paid per common share $ 0.61 $ 0.87 $ 1.48 $ 1.74
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.


4


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Three Months Ended Six Months Ended
June 30, June 30,
2020 2019 2020 2019
Net income $ 159,216 $ 150,040 $ 488,596 $ 442,342
Other comprehensive income (loss):
Foreign currency translation gain (loss) 13,015 ( 54,024 ) ( 252,562 ) 24,596
Derivative and financial instruments designated as hedges gain (loss) ( 27,171 ) 100,407 231,941 12,725
Total other comprehensive income (loss) ( 14,156 ) 46,383 ( 20,621 ) 37,321
Total comprehensive income (loss) 145,060 196,423 467,975 479,663
Less: Total comprehensive income (loss) attributable
to noncontrolling interests (1)
( 13,543 ) 14,665 ( 16,856 ) 32,284
Total comprehensive income (loss) attributable to common stockholders $ 158,603 $ 181,758 $ 484,831 $ 447,379
(1) Includes amounts attributable to redeemable noncontrolling interests.

5


CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended June 30, 2020
Common
Stock
Capital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Other
Equity
Noncontrolling
Interests
Total
Balances at January 1, 2020 $ 411,005 $ 20,190,107 $ ( 78,955 ) $ 7,353,966 $ ( 12,223,534 ) $ ( 112,157 ) $ 12 $ 966,183 $ 16,506,627
Cumulative change in accounting principle (Note 2) ( 5,212 ) ( 5,212 )
Balances at January 1, 2020 (as adjusted for change in accounting principle) 411,005 20,190,107 ( 78,955 ) 7,348,754 ( 12,223,534 ) ( 112,157 ) 12 966,183 16,501,415
Comprehensive income:
Net income (loss)
310,284 18,988 329,272
Other comprehensive income (loss)
15,944 ( 21,955 ) ( 6,011 )
Total comprehensive income 323,261
Net change in noncontrolling interests 37,625 ( 29,662 ) 7,963
Amounts related to stock incentive plans, net of forfeitures 246 6,608 ( 8,020 ) ( 1,166 )
Net proceeds from issuance of common stock 6,975 583,890 590,865
Dividends paid:
Common stock dividends
( 356,001 ) ( 356,001 )
Balances at March 31, 2020 $ 418,226 $ 20,818,230 $ ( 86,975 ) $ 7,659,038 $ ( 12,579,535 ) $ ( 96,213 ) $ 12 $ 933,554 $ 17,066,337
Comprehensive income:
Net income (loss)
179,246 18,659 197,905
Other comprehensive income (loss)
( 20,643 ) 6,298 ( 14,345 )
Total comprehensive income 183,560
Net change in noncontrolling interests 7,299 ( 70,124 ) ( 62,825 )
Amounts related to stock incentive plans, net of forfeitures 28 7,412 832 ( 8 ) 8,264
Net proceeds from issuance of common stock 89 3,604 3,693
Repurchase of common stock ( 7,656 ) ( 7,656 )
Dividends paid:
Common stock dividends
( 254,846 ) ( 254,846 )
Balances at June 30, 2020 $ 418,343 $ 20,836,545 $ ( 93,799 ) $ 7,838,284 $ ( 12,834,381 ) $ ( 116,856 ) $ 4 $ 888,387 $ 16,936,527
Six Months Ended June 30, 2019
Preferred
Stock
Common
Stock
Capital in
Excess of
Par Value
Treasury
Stock
Cumulative
Net Income
Cumulative
Dividends
Accumulated Other
Comprehensive
Income (Loss)
Other
Equity
Noncontrolling
Interests
Total
Balances at January 1, 2019 $ 718,498 $ 384,465 $ 18,424,368 $ ( 68,499 ) $ 6,121,534 $ ( 10,818,557 ) $ ( 129,769 ) $ 294 $ 954,265 $ 15,586,599
Comprehensive income:
Net income (loss)
280,470 10,785 291,255
Other comprehensive income (loss)
( 14,849 ) 5,787 ( 9,062 )
Total comprehensive income 282,193
Net change in noncontrolling interests ( 8,845 ) ( 1,497 ) ( 10,342 )
Amounts related to stock incentive plans, net of forfeitures 120 7,420 ( 5,993 ) ( 26 ) 1,521
Net proceeds from issuance of common stock 7,212 525,408 532,620
Conversion of preferred stock ( 718,498 ) 12,712 705,786
Dividends paid:
Common stock dividends
( 344,760 ) ( 344,760 )
Balances at March 31, 2019 $ $ 404,509 $ 19,654,137 $ ( 74,492 ) $ 6,402,004 $ ( 11,163,317 ) $ ( 144,618 ) $ 268 $ 969,340 $ 16,047,831
Comprehensive income:
Net income (loss)
137,762 11,349 149,111
Other comprehensive income (loss)
43,996 2,387 46,383
Total comprehensive income 195,494
Net change in noncontrolling interests ( 23,672 ) ( 7,959 ) ( 31,631 )
Amounts related to stock incentive plans, net of forfeitures 18 7,959 450 ( 80 ) 8,347
Net proceeds from issuance of common stock 1,487 101,721 103,208
Dividends paid:
Common stock dividends
( 353,677 ) ( 353,677 )
Balances at June 30, 2019 $ $ 406,014 $ 19,740,145 $ ( 74,042 ) $ 6,539,766 $ ( 11,516,994 ) $ ( 100,622 ) $ 188 $ 975,117 $ 15,969,572

6


CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
Six Months Ended
June 30,
2020 2019
Operating activities:
Net income $ 488,596 $ 442,342
Adjustments to reconcile net income to net cash provided from (used in) operating activities:
Depreciation and amortization
540,172 491,984
Other amortization expenses
6,947 9,761
Provision for loan losses
8,494 18,690
Impairment of assets
102,978 9,939
Stock-based compensation expense
14,373 15,192
Loss (gain) on derivatives and financial instruments, net
9,085 ( 574 )
Loss (gain) on extinguishment of debt, net
249 15,719
Loss (income) from unconsolidated entities
2,360 18,248
Rental income less than (in excess of) cash received
( 25,959 ) ( 53,234 )
Amortization related to above (below) market leases, net
( 1,008 ) ( 2 )
Loss (gain) on real estate dispositions, net
( 418,687 ) ( 165,727 )
Distributions by unconsolidated entities
6,795 46
Increase (decrease) in accrued expenses and other liabilities
22,348 55,415
Decrease (increase) in receivables and other assets
54,873 ( 3,317 )
Net cash provided from (used in) operating activities 811,616 854,482
Investing activities:
Cash disbursed for acquisitions, net of cash acquired
( 390,802 ) ( 2,718,808 )
Cash disbursed for capital improvements to existing properties
( 122,103 ) ( 124,176 )
Cash disbursed for construction in progress
( 93,031 ) ( 155,409 )
Capitalized interest
( 9,287 ) ( 6,256 )
Investment in loans receivable
( 19,538 ) ( 65,422 )
Principal collected on loans receivable
12,796 8,660
Other investments, net of payments
( 3,695 ) ( 16,973 )
Contributions to unconsolidated entities
( 225,739 ) ( 119,001 )
Distributions by unconsolidated entities
8,811 70,844
Proceeds from (payments on) derivatives
( 13,319 ) ( 21,643 )
Proceeds from sales of real property
1,998,087 616,820
Net cash provided from (used in) investing activities 1,142,180 ( 2,531,364 )
Financing activities:
Net increase (decrease) under unsecured credit facility and commercial paper
( 1,587,597 ) 722,188
Proceeds from issuance of senior unsecured notes
1,588,549 2,036,964
Payments to extinguish senior unsecured notes
( 1,050,000 )
Net proceeds from the issuance of secured debt
44,921 295,969
Payments on secured debt
( 345,340 ) ( 178,700 )
Net proceeds from the issuance of common stock
595,313 647,156
Repurchase of common stock
( 7,656 )
Payments for deferred financing costs and prepayment penalties
( 4,725 ) ( 24,177 )
Contributions by noncontrolling interests (1)
13,764 39,122
Distributions to noncontrolling interests (1)
( 180,875 ) ( 64,004 )
Cash distributions to stockholders
( 610,847 ) ( 695,099 )
Other financing activities
( 9,816 ) ( 8,615 )
Net cash provided from (used in) financing activities ( 504,309 ) 1,720,804
Effect of foreign currency translation on cash and cash equivalents and restricted cash ( 9,010 ) ( 333 )
Increase (decrease) in cash, cash equivalents and restricted cash 1,440,477 43,589
Cash, cash equivalents and restricted cash at beginning of period 385,766 316,129
Cash, cash equivalents and restricted cash at end of period $ 1,826,243 $ 359,718
Supplemental cash flow information:
Interest paid $ 227,632 $ 252,714
Income taxes paid (received), net ( 1,142 ) 2,040
(1) Includes amounts attributable to redeemable noncontrolling interests.

7

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business
Welltower Inc. (the "Company"), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties.
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2020 are not necessarily an indication of the results that may be expected for the year ending December 31, 2020. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2019.
Impact of COVID-19 Pandemic
The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the pandemic, the actions taken to contain the pandemic or mitigate its impact and the direct and indirect economic effects of the pandemic and containment measures, among others. The COVID-19 pandemic could have material and adverse effects on our financial condition, results of operations and cash flows in the future, including but not limited to, the following:
Our Seniors Housing Operating revenues are dependent on occupancy. Declines in occupancy are expected due to heightened move-in criteria and screening, as well as increased mortality rates among seniors. Occupancy within our total Seniors Housing Operating portfolio has declined as follows:

February March April May June July
Spot occupancy (1)
85.8 % 85.0 % 82.8 % 81.0 % 80.1 % 79.4 %
Sequential occupancy change ( 0.8 ) % ( 2.2 ) % ( 1.8 ) % ( 0.9 ) % ( 0.7 ) %

(1) Spot occupancy represents approximate month end occupancy for properties in operation as of February 2020, including unconsolidated properties but excluding acquisitions, dispositions and development conversions since the start of the COVID-19 pandemic.

Increased Seniors Housing Operating expenses are expected to continue until the pandemic subsides. We experienced incremental operational costs of $ 43,058,000 and $ 50,352,000 for the three and six months ended June 30, 2020, respectively, included in property operating expenses. These expenses were incurred as a result of the introduction of public health measures and other regulations affecting our properties, as well as additional health and safety measures adopted by us and our operators related to the COVID-19 pandemic, including increases in labor and property cleaning expenses and expenditures related to our efforts to procure PPE and supplies, net of reimbursements. Certain new expenses incurred since the start of the pandemic may continue on an ongoing basis as part of new health and safety protocols.
Our Triple-net operators are experiencing similar occupancy declines and expense increases, however, long-term/post-acute facilities are generally experiencing a higher degree of occupancy declines. These factors may impact our Triple-net operator's ability to pay rent and contractual obligations. Many of our Triple-net operators received funds under the Coronavirus Aid Relief, and Economic Security Act (“CARES Act”) and operators of long-term/post-acute facilities have also received funds under the CARES Act Provider Relief Fund. Accordingly, collection of Triple-net rent due during the COVID-19 pandemic to date (from March to July) has been consistent with historical collection rates and no significant rent concessions or deferrals have been made. Various local and state stay at home orders and the temporary closure of certain medical practices as a result may continue to impact our Outpatient Medical tenants' ability to pay rent. We have either collected or approved short term deferrals for over 99 % of Outpatient Medical rent due in the second quarter, consisting of 87 % cash collections and 12 % of short term deferrals. In most cases, the
8

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
deferred rent respresents two months of rent with expected repayment by the end of the year. Approximately 98 % of Outpatient Medical rent due in July was either collected or aproved for short term deferral, with cash collections accelerating to approximately 95 %. Short term deferrals of July rent decreased to 3 %, which primarily relates to tenants in local jurisdictions for which relief was mandated. Furthermore, collections of deferred rent due in June and July under executed deferrals were 96 %. To the extent that deferred rent is not repaid as expected, or the prolonged impact of the COVID-19 pandemic causes operators or tenants to seek further modifications of their lease agreements, we may recognize reductions in revenue and increases in uncollectible receivables.
Assessing properties for potential impairment involves subjectivity in determining if impairment indicators are present and in estimating the future undiscounted cash flows or estimated fair value of the asset. Key assumptions are made in these assessments including the estimation of future rental revenues, occupancy, operating expenses, capitalization rates and the ability and intent to hold the respective asset. All of these assumptions are significantly affected by our expectations of future market or economic conditions and can be highly impacted by the uncertainty of the COVID-19 pandemic. We will continue to evaluate the assumptions used in these analyses, changes to which may result in impairments in future periods.
The determination of the allowance for credit losses is based on our evaluation of collectability of our loans receivable and includes review of factors such as delinquency status, historical loan charge-offs, financial strength of the borrower and guarantors and the value of the underlying collateral. Reduced economic activity severely impacts our borrowers' businesses, financial conditions and liquidity and may hinder their ability to make contractual payments to us, leading to an increase in loans deemed to have deteriorated credit which could result in an increase in the provision for loan losses.
New Accounting Standards
On January 1, 2020, we adopted ASU 2016-13, “Measurement of Credit Losses on Financial Instruments" ("ASU 2016-13"). This standard requires a new forward-looking “expected loss” model to be used for receivables, held-to-maturity debt, loans, and other instruments. In November 2018, the FASB issued an amendment excluding operating lease receivables accounted for under the new leases standard from the scope of the new credit losses standard. ASU 2016-13 primarily impacts our measurement for credit losses related to our real estate and non-real estate loans receivable. In conjunction with our adoption of ASU 2016-13, we recorded a $ 5,212,000 increase to our allowance for credit losses on loans receivable (both real estate and non-real estate) with a corresponding adjustment to cumulative net income related to the change in accounting principle. See Note 7 for further details.
At the FASB's April 8, 2020 Board meeting, the staff acknowledged that the economics of lease concessions that result from a global pandemic may not be aligned with the underlying premise of the modification framework in ASC 842, under which the concession would be recognized over the remainder of the lease term. In a Q&A document, the FASB provided entities with COVID-19 related lease concessions an option to either (1) apply the modification framework for these concessions in accordance with ASC 842 as applicable or (2) account for concessions as if they were made under the enforceable rights included in the original agreement as long as total cash flows resulting from the modified contract are substantially the same or less than cash flows in the original contract. Due to the continuing adverse economic conditions caused by the COVID-19 pandemic, a subset of outpatient medical tenants have requested rent relief, most often in the form of a short-term rent deferral. Not all tenant requests result in modification of agreements, nor do we intend to forgo our contractual rights under our lease agreements. We evaluate each tenant's rent relief request on an individual basis. Generally we expect the majority of rent deferral agreements to result in two months of full or partial rent relief to repaid by the end of the year. We have elected to apply the accounting relief provided by the FASB to such short-term rent deferrals, and will account for such deferrals as if no change had been made to the original lease contract.
3. Real Property Acquisitions and Development
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income.
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
9

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Six Months Ended
June 30, 2020 June 30, 2019
Seniors Housing Operating Triple-net Outpatient
Medical
Totals Seniors Housing Operating Triple-net Outpatient
Medical
Totals
Land and land improvements $ 15,758 $ $ 40,847 $ 56,605 $ 103,743 $ 8,099 $ 132,154 $ 243,996
Buildings and improvements 132,480 765 171,457 304,702 1,109,966 96,244 1,198,608 2,404,818
Acquired lease intangibles 10,810 23,823 34,633 58,773 85,492 144,265
Construction in progress 36,174 36,174
Right of use assets, net 56,073 56,073
Receivables and other assets 257 139 396 4,560 376 4,936
Total assets acquired (1)
159,305 765 236,266 396,336 1,313,216 104,343 1,472,703 2,890,262
Secured debt ( 43,209 ) ( 43,209 )
Lease liabilities ( 45,287 ) ( 45,287 )
Accrued expenses and other liabilities ( 671 ) ( 2,036 ) ( 2,707 ) ( 8,677 ) ( 22,506 ) ( 31,183 )
Total liabilities acquired ( 671 ) ( 2,036 ) ( 2,707 ) ( 51,886 ) ( 67,793 ) ( 119,679 )
Noncontrolling interests (2)
( 2,827 ) ( 2,827 ) ( 38,830 ) ( 1,056 ) ( 39,886 )
Non-cash acquisition related activity (3)
( 11,889 ) ( 11,889 )
Cash disbursed for acquisitions 155,807 765 234,230 390,802 1,210,611 103,287 1,404,910 2,718,808
Construction in progress additions 53,705 26,262 26,677 106,644 110,902 24,131 26,587 161,620
Less: Capitalized interest ( 5,470 ) ( 1,826 ) ( 1,991 ) ( 9,287 ) ( 3,560 ) ( 908 ) ( 1,788 ) ( 6,256 )
Accruals (4)
( 1,343 ) ( 2,983 ) ( 4,326 ) 45 45
Cash disbursed for construction in progress 46,892 24,436 21,703 93,031 107,342 23,223 24,844 155,409
Capital improvements to existing properties 87,002 4,700 30,401 122,103 97,867 7,423 18,886 124,176
Total cash invested in real property, net of cash acquired $ 289,701 $ 29,901 $ 286,334 $ 605,936 $ 1,415,820 $ 133,933 $ 1,448,640 $ 2,998,393
(1) Excludes $ 580,000 and $ 1,910,000 of unrestricted and restricted cash acquired during the six months ended June 30, 2020 and 2019, respectively.
(2) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests.
(3) Relates to the acquisition of assets previously recognized as investments in unconsolidated entities.
(4) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, off-set by amounts paid in the current period.
Construction Activity
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
Six Months Ended
June 30, 2020 June 30, 2019
Development projects:
Seniors Housing Operating
$ 93,188 $ 28,117
Triple-net
33,627
Outpatient Medical
43,493
Total development projects
170,308 28,117
Expansion projects
35,637
Total construction in progress conversions $ 205,945 $ 28,117
4. Real Estate Intangibles
The following is a summary of our real estate intangibles, excluding those classified as held for sale, as of the dates indicated (dollars in thousands):
10

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2020 December 31, 2019
Assets:
In place lease intangibles $ 1,460,748 $ 1,513,836
Above market tenant leases 58,780 59,540
Lease commissions 46,450 43,675
Gross historical cost 1,565,978 1,617,051
Accumulated amortization ( 1,178,515 ) ( 1,181,158 )
Net book value $ 387,463 $ 435,893
Weighted-average amortization period in years 10.8 10.3
Liabilities:
Below market tenant leases $ 83,037 $ 99,035
Accumulated amortization ( 40,886 ) ( 49,390 )
Net book value $ 42,151 $ 49,645
Weighted-average amortization period in years 8.4 8.6
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Rental income related to (above)/below market tenant leases, net $ 402 $ 73 $ 925 $ ( 82 )
Amortization related to in place lease intangibles and lease commissions ( 33,316 ) ( 28,518 ) ( 69,293 ) ( 53,423 )
The future estimated aggregate amortization of intangible assets and liabilities is as follows for the periods presented (in thousands):
Assets Liabilities
2020 $ 54,296 $ 4,354
2021 66,013 8,162
2022 44,822 7,476
2023 36,282 5,238
2024 28,438 3,101
Thereafter 157,612 13,820
Total $ 387,463 $ 42,151
5. Dispositions and Assets Held for Sale
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At June 30, 2020, seven Seniors Housing Operating, three Triple-net, and 13 Outpatient Medical properties with an aggregate real estate balance of $ 382,580,000 were classified as held for sale. In addition to the real property balances held for sale, secured debt of $ 12,849,000 and net other assets and (liabilities) of $ 35,085,000 are included in the Consolidated Balance Sheet related to the held for sale properties. Expected gross sales proceeds related to the held for sale properties is approxi mately $ 501,008,000 .
During the three months ended June 30, 2020, the expected sale of a Seniors Housing Operating portfolio, which had previously met the held for sale criteria, was not completed. As a result, 11 properties with a carrying value of $ 386,744,000 were reclassified to held for use.
During the three months ended March 31, 2020, we recorded impairment charges of $ 27,827,000 related to certain held for use properties for which the carrying value exceeded the fair values. During the three months ended June 30, 2020, we entered into and subsequently closed a definitive purchase and sale agreement to sell six Seniors Housing Operating properties. In conjunction with this transaction, an impairment charge of $ 56,371,000 was recognized. During the three months ended June 30, 2020, we agreed to terms including pricing for the sale of a portfolio of six Seniors Housing Operating properties previously classified as held for sale resulting in an impairment charge of $ 18,780,000 . The following is a summary of our real property disposition activity for the periods presented (in thousands):
11

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Six Months Ended June 30,
2020 2019
Real estate dispositions:
Seniors Housing Operating
$ 706,964 $ 8,726
Triple-net
33,445 442,865
Outpatient Medical
808,992
Total dispositions
1,549,401 451,591
Gain (loss) on real estate dispositions, net 418,687 165,727
Net other assets/liabilities disposed
29,999 ( 498 )
Proceeds from real estate dispositions $ 1,998,087 $ 616,820
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations, are not reclassified on our Consolidated Statements of Comprehensive Income. The following represents the activity related to these properties for the periods presented (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Revenues:
Total revenues
$ 36,481 $ 177,276 $ 107,933 $ 355,819
Expenses:
Interest expense
1,622 4,210 4,591 8,420
Property operating expenses
23,850 101,416 63,300 207,340
Provision for depreciation
7,637 29,488 18,254 58,692
Total expenses
33,109 135,114 86,145 274,452
Income (loss) from real estate dispositions, net $ 3,372 $ 42,162 $ 21,788 $ 81,367
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.
The components of lease expense were as follows for the period presented (in thousands):
Six Months Ended
Classification June 30, 2020 June 30, 2019
Operating lease cost: (1)
Real estate lease expense Property operating expenses $ 12,516 $ 14,679
Non-real estate investment lease expense General and administrative expenses 2,549 770
Finance lease cost:
Amortization of leased assets Property operating expenses 4,043 4,245
Interest on lease liabilities Interest expense 2,695 2,169
Sublease income Rental income ( 2,087 ) ( 2,087 )
Total $ 19,716 $ 19,776
(1) Includes short-term leases which are immaterial.

Supplemental balance sheet information related to leases is as follows (in thousands):
12

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

Classification June 30, 2020 December 31, 2019
Right of use assets:
Operating leases - real estate Right of use assets, net $ 344,011 $ 374,217
Finance leases - real estate Right of use assets, net 158,593 162,216
Real estate right of use assets, net 502,604 536,433
Operating leases - non-real estate investments Receivables and other assets 11,063 12,474
Total right of use assets, net $ 513,667 $ 548,907
Lease liabilities:
Operating leases $ 339,589 $ 364,803
Financing leases 107,835 108,890
Total $ 447,424 $ 473,693
Substantially all of our operating leases in which we are the lessor contain escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. During the three months ended March 31, 2020, we wrote off straight-line receivables of $ 32,268,000 in conjunction with the execution of a lease amendment. Additionally, during the three months ended June 30, 2020, we recorded a reserve of $ 1,842,000 on straight-line receivable balances deemed uncollectible.
Leases in our Triple-net and Outpatient Medical portfolios typically include some form of operating expense reimbursement by the tenant. For the six months ended June 30, 2020, we recognized $ 786,265,000 of rental income related to operating leases, of which $ 104,605,000 was for variable lease payments which primarily represents the reimbursement of operating costs such as common area maintenance expenses, utilities, insurance and real estate taxes. For the six months ended June 30, 2019, we recognized $ 766,670,000 of rental income related to operating leases, of which $ 94,017,000 was for variable lease payments.
7. Loans Receivable
Loans receivable are recorded on our Consolidated Balance Sheets in real estate loans receivable, net of allowance for credit losses, or for non-real estate loans receivable, in receivables and other assets, net of allowance for credit losses. Real estate loans receivable consists of mortgage loans and other real estate loans which are primarily collateralized by a first, second or third mortgage lien, a leasehold mortgage on, or an assignment of the partnership interest in, the related properties, corporate guarantees and/or personal guarantees. Non-real estate loans are generally corporate loans with no real estate backing. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of the risk of credit loss. Accrued interest receivable was $ 10,171,000 and $ 6,897,000 as of June 30, 2020 and December 31, 2019, respectively, and is included in receivables and other assets on the Consolidated Balance Sheets. The following is a summary of our loans receivable (in thousands):
June 30, 2020 December 31, 2019
Mortgage loans $ 102,275 $ 188,062
Other real estate loans 126,448 124,696
Allowance for credit losses on real estate loans receivable ( 3,852 ) ( 42,376 )
Real estate loans receivable, net of credit allowance 224,871 270,382
Non-real estate loans 451,968 362,850
Allowance for credit losses on non-real estate loans receivable ( 78,133 ) ( 25,996 )
Non-real estate loans receivable, net of credit allowance 373,835 336,854
Total loans receivable, net of credit allowance $ 598,706 $ 607,236
During the six months ended June 30, 2020, the real estate collateral associated with one loan was released, therefore, the principal balance of $ 86,411,000 and related allowance for credit losses of $ 42,376,000 was reclassified to a non-real estate loan.


13

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our loan activity for the periods presented (in thousands):
Six Months Ended
June 30, 2020 June 30, 2019
Advances on loans receivable:
Investments in new loans
$ 2,477 $ 30,000
Draws on existing loans
17,061 35,422
Net cash advances on loans receivable
19,538 65,422
Receipts on loans receivable:
Loan payoffs
4,384
Principal payments on loans
12,796 4,276
Net cash receipts on loans receivable
12,796 8,660
Net cash advances (receipts) on loans receivable $ 6,742 $ 56,762
The allowance for credit loss on loans receivable is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the credit allowance is based on a quarterly evaluation of each of these loans, including general economic conditions and estimated collectability of loan payments. We evaluate the collectability of our loans receivable based on a combination of credit quality indicators, including, but not limited to, payment status, historical loan charge-offs, financial strength of the borrower and guarantors, and nature, extent, and value of the underlying collateral.
A loan is considered to have deteriorated credit quality when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the loan agreement. For those loans we identified as having deteriorated credit quality we determine the amount of credit loss on an individual basis. Placement on non-accrual status may be required. Consistent with this definition, all loans on non-accrual are deemed to have deteriorated credit quality. To the extent circumstances improve and the risk of collectability is diminished, we will return these loans to income accrual status. While a loan is on non-accrual status, any cash receipts are applied against the outstanding principal balance.
For the remaining loans we assess credit loss on a collective pool basis and use our historical loss experience for similar loans to determine the reserve for credit losses. The following is a summary of our loans by credit loss category (in thousands):
June 30, 2020
Loan category Years of Origination Loan Carrying Value Allowance for Credit Loss Net Loan Balance No. of Loans
Deteriorated loans 2007 - 2018 $ 186,584 $ ( 76,695 ) $ 109,889 5
Collective loan pool 2007 - 2015 128,447 ( 1,866 ) 126,581 15
Collective loan pool (1)
2016 184,620 ( 1,572 ) 183,048 6
Collective loan pool 2017 119,662 ( 999 ) 118,663 7
Collective loan pool 2018 15,399 ( 224 ) 15,175 1
Collective loan pool 2019 45,979 ( 629 ) 45,350 7
Total loans $ 680,691 $ ( 81,985 ) $ 598,706 41
(1) Carrying value is exclusive of deferred gains of $ 62,819,000 recorded in accrued expenses and other liabilities on the Consolidated Balance Sheets.
In March 2019, we recognized a provision for loan losses of $ 18,690,000 to fully reserve for certain Triple-net real estate loans receivable that were no longer deemed collectible. During the quarter ended June 30, 2019, these loans were written off. During the six months ended June 30, 2020, we recognized a provision for credit losses of $ 6,898,000 to fully reserve for one Triple-net non-real estate loan receivable and $ 1,303,000 to fully reserve for one Triple-net real estate loan receivable that were no longer deemed collectible. The following is a summary of the allowance for credit losses on loans receivable for the periods presented (in thousands):
14

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Six Months Ended
June 30, 2020 June 30, 2019
Balance at beginning of period $ 68,372 $ 68,372
Adoption of ASU 2016-13 5,212
Provision for loan losses 8,494 18,690
Loan write-offs ( 18,690 )
Foreign currency translation ( 93 )
Balance at end of period $ 81,985 $ 68,372
The following is a summary of our deteriorated loans (in thousands):
Six Months Ended
June 30, 2020 June 30, 2019
Balance of deteriorated loans at end of period (1)
$ 186,584 $ 188,068
Allowance for credit losses ( 76,695 ) ( 68,372 )
Balance of deteriorated loans not reserved $ 109,889 $ 119,696
Interest recognized on deteriorated loans (2)
$ 7,912 $ 7,964
(1) Current year amounts include $ 10,716,000 and $ 2,534,000 of loans on non-accrual as of June 30, 2020 and December 31, 2019, respectively. Prior year amounts include $ 2,534,000 and$ 2,567,000 as of June 30, 2019 and December 31, 2018, respectively.
(2) Represents cash interest recognized in the period.
8. Investments in Unconsolidated Entities
We participate in a number of joint ventures, which generally invest in seniors housing and health care real estate. The results of operations for these properties have been included in our consolidated results of operations from the date of acquisition by the joint ventures and are reflected in our Consolidated Statements of Comprehensive Income as income or loss from unconsolidated entities. The following is a summary of our investments in unconsolidated entities (dollars in thousands):
Percentage Ownership (1)
June 30, 2020 December 31, 2019
Seniors Housing Operating
10 % to 50 %
$ 568,381 $ 463,741
Triple-net
10 % to 25 %
7,172 7,740
Outpatient Medical
15 % to 50 %
211,368 111,942
Total $ 786,921 $ 583,423
(1) Excludes ownership of in substance real estate.
At June 30, 2020, the aggregate unamortized basis difference of our joint venture investments of $ 112,486,000 is primarily attributable to the difference between the amount for which we purchase our interest in the entity, including transaction costs, and the historical carrying value of the net assets of the joint venture. This difference is being amortized over the remaining useful life of the related properties and included in the reported amount of income from unconsolidated entities.
We have made loans totaling $ 250,215,000 related to eight properties as of June 30, 2020 for the development and construction of certain properties which are classified as in substance real estate investments. We believe that such borrowers typically represent variable interest entities ("VIE" or "VIEs") in accordance with ASC 810 Consolidation. VIEs are required to be consolidated by their primary beneficiary ("PB") which is the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impacts the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. We have concluded that we are not the PB of such borrowers, therefore, the loan arrangements were assessed based on among other factors, the amount and timing of expected residual profits, the estimated fair value of the collateral and the significance of the borrower's equity in the project. Based on these assessments, the arrangements have been classified as in substance real estate investments. We expect to fund an additional $ 212,306,000 related to these investments.
9. Credit Concentration
We use consolidated net operating income (“NOI”) as our credit concentration metric. See Note 18 for additional information and reconciliation. The following table summarizes certain information about our credit concentration for the six months ended June 30, 2020, excluding our share of NOI in unconsolidated entities (dollars in thousands):
15

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Concentration by relationship: (1)
Number of Properties Total NOI
Percent of NOI (2)
Sunrise Senior Living (3)
165 $ 134,872 12 %
ProMedica 215 106,530 10 %
Genesis Healthcare 52 58,831 5 %
Revera (3)
94 57,268 5 %
Avery Healthcare 59 37,298 3 %
Remaining portfolio 941 709,733 65 %
Totals 1,526 $ 1,104,532 100 %
(1) Sunrise Senior Living and Revera are in our Seniors Housing Operating segment. Genesis Healthcare and ProMedica are in our Triple-net segment. Avery Healthcare is in both the Triple-net and Seniors Housing Operating segments.
(2) NOI with our top five relationships comprised 37 % of total NOI for the year ended December 31, 2019.
(3) Revera owns a controlling interest in Sunrise Senior Living.

10. Borrowings Under Credit Facilities and Commercial Paper Program
At June 30, 2020, we had a primary unsecured credit facility with a consortium of 31 banks that includes a $ 3,000,000,000 unsecured revolving credit facility (none outstanding at June 30, 2020), a $ 500,000,000 unsecured term credit facility and a $ 250,000,000 Canadian-denominated unsecured term credit facility. We have an option, through an accordion feature, to upsize the unsecured revolving credit facility and the $ 500,000,000 unsecured term credit facility by up to an additional $ 1,000,000,000 , in the aggregate, and the $ 250,000,000 Canadian-denominated unsecured term credit facility by up to an additional $ 250,000,000 . The primary unsecured credit facility also allows us to borrow up to $ 1,000,000,000 in alternate currencies ( none outstanding at June 30, 2020). Borrowings under the unsecured revolving credit facility are subject to interest payable at the applicable margin over LIBOR interest rate. The applicable margin is based on our debt ratings and was 0.825 % at June 30, 2020. In addition, we pay a facility fee quarterly to each bank based on the bank’s commitment amount. The facility fee depends on our debt ratings and was 0.15 % at June 30, 2020. The term credit facilities mature on July 19, 2023. The revolving credit facility is scheduled to mature on July 19, 2022 and can be extended for two successive terms of six months each at our option.
In January 2019, we established an unsecured commercial paper program. Under the terms of the program, we may issue unsecured commercial paper notes with maturities that vary, but do not exceed 397 days from the date of issue, up to a maximum aggregate face or principal amount outstanding at any time o f $ 1,000,000,000 (none outstanding at June 30, 2020).
The following information relates to aggregate borrowings under the unsecured revolving credit facility and commercial paper program for the periods presented (dollars in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Balance outstanding at quarter end $ $ 1,870,000 $ $ 1,870,000
Maximum amount outstanding at any month end $ 685,000 $ 2,880,000 $ 2,100,000 $ 2,880,000
Average amount outstanding (total of daily
principal balances divided by days in period)
$ 405,165 $ 1,807,631 $ 999,490 $ 1,301,883
Weighted average interest rate (actual interest
expense divided by average borrowings outstanding)
1.57 % 3.08 % 2.08 % 3.11 %
11. Senior Unsecured Notes and Secured Debt
We may repurchase, redeem or refinance senior unsecured notes from time to time, taking advantage of favorable market conditions when available. We may purchase senior notes for cash through open market purchases, privately negotiated transactions, a tender offer or, in some cases, through the early redemption of such securities pursuant to their terms. The senior unsecured notes are redeemable at our option, at any time in whole or from time to time in part, at a redemption price equal to the sum of: (i) the principal amount of the notes (or portion of such notes) being redeemed plus accrued and unpaid interest thereon up to the redemption date and (ii) any “make-whole” amount due under the terms of the notes in connection with early redemptions. Redemptions and repurchases of debt, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. At June 30, 2020, the annual principal payments due on these debt obligations were as follows (in thousands):
16

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Senior
Unsecured Notes (1,2)
Secured
Debt (1,3)
Totals
2020 $ $ 257,139 $ 257,139
2021 427,969 427,969
2022 (4)
1,010,000 444,119 1,454,119
2023 (5,6)
1,783,621 327,388 2,111,009
2024 1,350,000 176,366 1,526,366
Thereafter (7,8,9)
7,769,090 995,008 8,764,098
Totals $ 11,912,711 $ 2,627,989 $ 14,540,700
(1) Amounts represent principal amounts due and do not include unamortized premiums/discounts, debt issuance costs, or other fair value adjustments as reflected on the Consolidated Balance Sheet.
(2) Annual interest rates range from 0.88 % to 6.50 %.
(3) Annual interest rates range from 0.12 % to 12.00 %. Carrying value of the properties securing the debt totaled $ 5,774,000 at June 30, 2020.
(4) Includes a $ 1,000,000,000 unsecured term credit facility. The loan matures on April 1, 2022 and bears interest at LIBOR plus 1.20 % ( 1.38 % at June 30, 2020).
(5) Includes a $ 250,000,000 Canadian-denominated unsecured term credit facility (approximately $ 183,621,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2020). The loan matures on July 19, 2023 and bears interest at the Canadian Dealer Offered Rate plus 0.9 % ( 1.42 % at June 30, 2020).
(6) Includes a $ 500,000,000 unsecured term credit facility. The loan matures on July 19, 2023 and bears interest at LIBOR plus 0.9 % ( 1.09 % at June 30, 2020). (7) Includes a $ 300,000,000 Canadian-denominated 2.95 % senior unsecured notes due 2027 (approximately $ 220,345,000 based on the Canadian/U.S. Dollar exchange rate on June 30, 2020).
(8) Includes a £ 550,000,000 4.80 % senior unsecured notes due 2028 (approximately $ 680,295,000 based on the Sterling/U.S. Dollar exchange rate in effect on June 30, 2020).
(9) Includes a $ 500,000,000 4.50 % senior unsecured notes due 2034 (approximately $ 618,450,000 based on the Sterling/U.S. Dollar exchange rate in effect on June 30, 2020).

The following is a summary of our senior unsecured notes principal activity during the periods presented (dollars in thousands):
Six Months Ended
June 30, 2020 June 30, 2019
Weighted Avg. Weighted Avg.
Amount Interest Rate Amount Interest Rate
Beginning balance $ 10,427,562 4.03 % $ 9,699,984 4.48 %
Debt issued 1,600,000 1.89 % 2,050,000 3.58 %
Debt extinguished % ( 1,050,000 ) 4.98 %
Foreign currency ( 114,851 ) 4.30 % 11,572 3.52 %
Ending balance $ 11,912,711 3.65 % $ 10,711,556 4.24 %
In April, we closed on our previously announced $ 1.0 billion two-year unsecured term loan due April 2022. The term loan bears interest at a rate of 1-month LIBOR + 1.20 %, based on our credit rating. On June 30, 2020, we completed the issuance of $ 600 million senior unsecured notes bearing interest at 2.75 % with a maturity date of January 2031. On July 1, 2020 net proceeds were used to extinguish $ 160,872,000 of our 3.75 % senior unsecured notes due March 2023 and $ 265,376,000 of our 3.95 % senior unsecured notes due September 2023. We recognized a loss on extinguishment of $ 31,940,000 in July in conjunction with the transaction. Additionally, on July 2, 2020 we repaid $ 140,000,000 on our unsecured term loan.
The following is a summary of our secured debt principal activity for the periods presented (dollars in thousands):
Six Months Ended
June 30, 2020 June 30, 2019
Weighted Avg. Weighted Avg.
Amount Interest Rate Amount Interest Rate
Beginning balance $ 2,993,342 3.63 % $ 2,485,711 3.90 %
Debt issued 44,921 2.58 % 295,969 3.52 %
Debt assumed % 42,000 4.62 %
Debt extinguished ( 314,631 ) 2.94 % ( 151,473 ) 4.42 %
Principal payments ( 30,709 ) 3.55 % ( 27,227 ) 3.74 %
Foreign currency ( 64,934 ) 3.13 % 45,002 3.37 %
Ending balance $ 2,627,989 3.09 % $ 2,689,982 3.84 %
17

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2020, we were in compliance with all of the covenants under our debt agreements.
12. Derivative Instruments
We are exposed to, among other risks, the impact of changes in foreign currency exchange rates as a result of our non-U.S. investments and interest rate risk related to our capital structure. Our risk management program is designed to manage the exposure and volatility arising from these risks, and utilizes foreign currency forward contracts, cross currency swap contracts, interest rate swaps, interest rate locks and debt issued in foreign currencies to offset a portion of these risks.
Foreign Currency Forward Contracts Designated as Cash Flow Hedges
For instruments that are designated and qualify as a cash flow hedge, the effective portion of the gain or loss on the derivative is deferred as a component of other comprehensive income (“OCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in earnings.
Cash Flow Hedges of Interest Rate Risk
We enter into interest rate swaps in order to maintain a capital structure containing targeted amounts of fixed and floating-rate debt and manage interest rate risk. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for our fixed-rate payments. These interest rate swap agreements were used to hedge the variable cash flows associated with variable-rate debt.
Periodically, we enter into and designate interest rate locks to partially hedge the risk of changes in interest payments attributable to increases in the benchmark interest rate during the period leading up to the probable issuance of fixed-rate debt. We designate our interest rate locks as cash flow hedges. Gains and losses when we settle our interest rate locks are amortized into income over the life of the related debt, except where a material amount is deemed to be ineffective, which would be immediately reclassified to the Consolidated Statements of Comprehensive Income.
Foreign Currency Forward Contracts and Cross Currency Swap Contracts Designated as Net Investment Hedges
We use foreign currency forward and cross currency forward swap contracts to hedge a portion of the net investment in foreign subsidiaries against fluctuations in foreign exchange rates. For instruments that are designated and qualify as net investment hedges, the variability in the foreign currency to U.S. Dollar of the instrument is recorded as a cumulative translation adjustment component of OCI.
During the six months ended June 30, 2020 and 2019, we settled certain net investment hedges generating cash proceeds of $ 3,485,000 and $ 6,716,000 , respectively. The balance of the cumulative translation adjustment will be reclassified to earnings if the hedged investment is sold or substantially liquidated.
Derivative Contracts Undesignated
We use foreign currency exchange contracts to manage existing exposures to foreign currency exchange risk. Gains and losses resulting from the changes in fair value of these instruments are recorded in interest expense on the Consolidated Statements of Comprehensive Income and are substantially offset by net revaluation impacts on foreign currency denominated balance sheet exposures. In addition, we have several interest rate cap contracts related to variable rate secured debt agreements. Gains and losses resulting from the changes in fair values of these instruments are also recorded in interest expense.
The following presents the notional amount of derivatives and other financial instruments as of the dates indicated (in thousands):
18

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 2020 December 31, 2019
Derivatives designated as net investment hedges:
Denominated in Canadian Dollars $ 650,000 $ 725,000
Denominated in Pounds Sterling £ 1,340,708 £ 1,340,708
Financial instruments designated as net investment hedges:
Denominated in Canadian Dollars $ 250,000 $ 250,000
Denominated in Pounds Sterling £ 1,050,000 £ 1,050,000
Interest rate swaps designated as cash flow hedges:
Denominated in U.S Dollars (1)
$ 1,188,250 $ 1,188,250
Derivative instruments not designated:
Interest rate caps denominated in U.S. Dollars $ 112,726 $ 405,819
Forward sales contracts denominated in Canadian Dollars $ 80,000 $
Forward purchase contracts denominated in Pounds Sterling £ £ ( 125,000 )
Forward sales contracts denominated in Pounds Sterling £ £ 125,000
(1) At June 30, 2020 the maximum maturity date was July 15, 2021.
The following presents the impact of derivative instruments on the Consolidated Statements of Comprehensive Income for the periods presented (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
Description Location 2020 2019 2020 2019
Gain (loss) on derivative instruments designated as hedges recognized in income Interest expense $ 4,106 $ 7,134 $ 10,751 $ 12,467
Gain (loss) on derivative instruments not designated as hedges recognized in income Interest expense $ ( 1,953 ) $ ( 1,128 ) $ ( 2,048 ) $ ( 2,666 )
Gain (loss) on derivative and financial instruments designated as hedges recognized in OCI OCI $ ( 27,171 ) $ 100,407 $ 231,941 $ 12,725
13. Commitments and Contingencies
At June 30, 2020, we had 8 outstanding letter of credit obligations totaling $ 37,014,000 and expiring between 2020 and 2024. At June 30, 2020, we had outstanding construction in progress of $ 411,700,000 and were committed to providing additional funds of approximately $ 332,074,000 to complete construction. Additionally, at June 30, 2020, we had outstanding investments classified as in substance real estate of $ 250,215,000 and were committed to provide additional funds of $ 212,306,000 (see Note 8 for additional information). Purchase obligations at June 30, 2020 also include $ 19,442,000 of contingent purchase obligations to fund capital improvements. Rents due from the tenant are increased to reflect the additional investment in the property.
14. Stockholders’ Equity
The following is a summary of our stockholders’ equity capital accounts as of the dates indicated:
June 30, 2020 December 31, 2019
Preferred Stock:
Authorized shares 50,000,000 50,000,000
Issued shares
Outstanding shares
Common Stock, $1.00 par value:
Authorized shares 700,000,000 700,000,000
Issued shares 418,869,381 411,550,857
Outstanding shares 417,302,448 410,256,615
Preferred Stock The following is a summary of our preferred stock activity during the periods indicated:
19

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Six Months Ended
June 30, 2020 June 30, 2019
Weighted Avg. Weighted Avg.
Shares Dividend Rate Shares Dividend Rate
Beginning balance % 14,369,965 6.50 %
Shares converted % ( 14,369,965 ) 6.50 %
Ending balance % %
During the six months ended June 30, 2019, we converted all of the outstanding Series I Preferred Stock. Each share was converted into 0.8857 shares of common stock.
Common Stock In February 2019, we entered into an amended and restated equity distribution agreement whereby we can offer and sell up to $ 1,500,000,000 aggregate amount of our common stock ("Equity Shelf Program"). The Equity Shelf Program also allows us to enter into forward sale agreements. During the six months ended June 30, 2020, we physically settled all of our outstanding forward sales agreements for cash proceeds of $ 576,196,000 . As of June 30, 2020, we h ad $ 499,341,000 of remaining capacity under the Equity Shelf Program.
On May 1, 2020, our Board of Directors authorized a share repurchase program whereby we may repurchase up to $ 1 billion of common stock through December 31, 2021 (the "Repurchase Program"). Under this authorization, we are not required to purchase shares but may choose to do so in the open market or through private transactions at times and amounts based on our evaluation of market conditions and other factors. We expect to finance any share repurchases under the Repurchase Program using available cash and may use proceeds from borrowings or debt offerings. During the six months ended June 30, 2020, we repurchased 201,947 shares at an averag e price of $ 37.89 per share.

The following is a summary of our common stock issuances during the six months ended June 30, 2020 and 2019 (dollars in thousands, except shares and average price amounts):
Shares Issued Average Price Gross Proceeds Net Proceeds
2019 Dividend reinvestment plan issuances 4,304,712 $ 75.20 $ 323,724 $ 320,243
2019 Option exercises 10,736 51.32 551 551
2019 Equity shelf program issuances 4,384,045 74.97 328,665 326,362
2019 Preferred stock conversions 12,712,452
2019 Stock incentive plans, net of forfeitures 167,565
2019 Totals 21,579,510 $ 652,940 $ 647,156
2020 Dividend reinvestment plan issuances 264,153 $ 72.33 $ 19,105 $ 19,105
2020 Option exercises 251 47.81 12 12
2020 Equity shelf program issuances 6,799,978 86.48 588,072 576,196
2020 Stock incentive plans, net of forfeitures 183,398
2020 Totals 7,247,780 $ 607,189 $ 595,313
Dividends The decrease in dividends is attributable to the declaration of a reduced cash dividend beginning with the quarter ending March 31, 2020. The following is a summary of our dividend payments (in thousands, except per share amounts):
Six Months Ended
June 30, 2020 June 30, 2019
Per Share Amount Per Share Amount
Common stock $ 1.48 $ 610,847 $ 1.74 $ 698,437
Accumulated Other Comprehensive Income The following is a summary of accumulated other comprehensive income (loss) for the periods presented (in thousands):
June 30, 2020 December 31, 2019
Foreign currency translation $ ( 956,454 ) $ ( 719,814 )
Derivative and financial instruments designated as hedges 839,598 607,657
Total accumulated other comprehensive income (loss) $ ( 116,856 ) $ ( 112,157 )
20

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

15. Stock Incentive Plans
Our 2016 Long-Term Incentive Plan (“2016 Plan”) authorizes up to 10,000,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. Our non-employee directors, officers and key employees are eligible to participate in the 2016 Plan. The 2016 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock, deferred stock units, performance units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years . Options expire ten years from the date of grant. Stock-based compensation expense totaled $ 7,290,000 and $ 14,373,000 for the three and six months ended June 30, 2020, respectfully, and $ 7,662,000 and $ 15,192,000 for the same periods in 2019.
16. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):
Three Months Ended June 30, Six Months Ended June 30,
2020 2019 2020 2019
Numerator for basic earnings per share - net income (loss) attributable to common stockholders
$ 179,246 $ 137,762 $ 489,530 $ 418,232
Adjustment for net income (loss) attributable to OP units
( 1,366 ) 35 ( 2,754 ) 88
Numerator for diluted earnings per share
$ 177,880 $ 137,797 $ 486,776 $ 418,320
Denominator for basic earnings per share - weighted average shares 417,084 404,607 413,696 398,073
Effect of dilutive securities:
Employee stock options
1
Non-vested restricted shares
619 955 661 911
Redeemable OP units
1,396 1,096 1,396 1,096
Employee stock purchase program
22 15 22 15
Dilutive potential common shares 2,037 2,066 2,079 2,023
Denominator for diluted earnings per share - adjusted weighted average shares
419,121 406,673 415,775 400,096
Basic earnings per share $ 0.43 $ 0.34 $ 1.18 $ 1.05
Diluted earnings per share $ 0.42 $ 0.34 $ 1.17 $ 1.05
17. Disclosure about Fair Value of Financial Instruments
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A three-level valuation hierarchy exists for disclosures of fair value measurements based upon the transparency of inputs to the valuation of an asset or liability as of the measurement date. A financial instrument's categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Please see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 for additional information. The three levels are defined below:
Level 1 - Quoted prices in active markets for identical assets or liabilities.
Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate that value.
Mortgage Loans, Other Real Estate Loans and Non-real Estate Loans Receivable — The fair value of mortgage loans, other real estate loans and non-real estate loans receivable is generally estimated by using Level 2 and Level 3 inputs such as discounting the estimated future cash flows using the current rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities.
Cash and Cash Equivalents and Restricted Cash — The carrying amount approximates fair value.
Equity Securities — Equity securities are recorded at their fair value based on Level 1 publicly available trading prices.

21

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Borrowings Under Primary Unsecured Credit Facility and Commercial Paper Program — The carrying amount of the primary unsecured credit facility and commercial paper program approximates fair value because the borrowings are interest rate adjustable.
Senior Unsecured Notes — The fair value of the senior unsecured notes payable was estimated based on Level 1 publicly available trading prices. The carrying amount of the variable rate senior unsecured notes approximates fair value because they are interest rate adjustable.
Secured Debt — The fair value of fixed rate secured debt is estimated using Level 2 inputs by discounting the estimated future cash flows using the current rates at which similar loans would be made with similar credit ratings and for the same remaining maturities. The carrying amount of variable rate secured debt approximates fair value because the borrowings are interest rate adjustable.
Foreign Currency Forward Contracts, Interest Rate Swaps and Cross Currency Swaps — Foreign currency forward contracts, interest rate swaps and cross currency swaps are recorded in other assets or other liabilities on the balance sheet at fair value that is derived from observable market data, including yield curves and foreign exchange rates (all of our derivatives are Level 2).
Redeemable OP Unitholder Interests — Our redeemable OP unitholder interests are recorded on the balance sheet at fair value using Level 2 inputs unless the fair value is below the initial amount in which case the redeemable OP unitholder interests are recorded at the initial amount adjusted for distributions to the unitholders and income or loss attributable to the unitholders. The fair value is measured using the closing price of our common stock, as units may be redeemed at the election of the holder for cash or, at our option, one share of our common stock per unit, subject to adjustment in certain circumstances.
The carrying amounts and estimated fair values of our financial instruments are as follows (in thousands):
June 30, 2020 December 31, 2019
Carrying Amount Fair Value Carrying Amount Fair Value
Financial assets:
Mortgage loans receivable $ 100,782 $ 107,407 $ 145,686 $ 150,217
Other real estate loans receivable 124,089 124,291 124,696 128,512
Equity securities 6,600 6,600 15,685 15,685
Cash and cash equivalents 1,678,770 1,678,770 284,917 284,917
Restricted cash 147,473 147,473 100,849 100,849
Non-real estate loans receivable 373,835 419,325 336,854 379,239
Foreign currency forward contracts, interest rate swaps and cross currency swaps 165,968 165,968 18,554 18,554
Financial liabilities:
Borrowings under unsecured credit facility and commercial paper program $ $ $ 1,587,597 $ 1,587,597
Senior unsecured notes 11,815,972 12,890,274 10,336,513 11,400,571
Secured debt 2,619,678 2,668,133 2,990,962 3,041,893
Foreign currency forward contracts, interest rate swaps and cross currency swaps 64,077 64,077 53,601 53,601
Redeemable OP unitholder interests $ 97,179 $ 92,373 $ 121,440 $ 121,440
Items Measured at Fair Value on a Recurring Basis
The market approach is utilized to measure fair value for our financial assets and liabilities reported at fair value on a recurring basis. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The following summarizes items measured at fair value on a recurring basis (in thousands):
Fair Value Measurements as of June 30, 2020
Total Level 1 Level 2 Level 3
Equity securities $ 6,600 $ 6,600 $ $
Foreign currency forward contracts, interest rate swaps and cross currency swaps, net asset (liability) (1)
101,891 101,891
Totals $ 108,491 $ 6,600 $ 101,891 $
(1) Please see Note 12 for additional information.
22

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Items Measured at Fair Value on a Nonrecurring Basis
In addition to items that are measured at fair value on a recurring basis, we also have assets and liabilities in our balance sheet that are measured at fair value on a nonrecurring basis that are not included in the tables above. Assets, liabilities and noncontrolling interests that are measured at fair value on a nonrecurring basis include those acquired or assumed. Asset impairments (if applicable, see Note 5 for impairments of real property and Note 7 for impairments of loans receivable) are also measured at fair value on a nonrecurring basis. We have determined that the fair value measurements included in each of these assets and liabilities rely primarily on company-specific inputs and our assumptions about the use of the assets and settlement of liabilities, as observable inputs are not available. As such, we have determined that each of these fair value measurements generally resides within Level 3 of the fair value hierarchy. We estimate the fair value of real estate and related intangibles using the income approach and unobservable data such as net operating income and estimated capitalization and discount rates. We also consider local and national industry market data including comparable sales, and commonly engage an external real estate appraiser to assist us in our estimation of fair value. We estimate the fair value of assets held for sale based on current sales price expectations or, in the absence of such price expectations, Level 3 inputs described above. We estimate the fair value of loans receivable using projected payoff valuations based on the expected future cash flows and/or the estimated fair value of collateral, net of sales costs, if the repayment of the loan is expected to be provided solely by the collateral. We estimate the fair value of secured debt assumed in asset acquisitions using current interest rates at which similar borrowings could be obtained on the transaction date.
18. Segment Reporting
We invest in seniors housing and health care real estate. We evaluate our business and make resource allocations on our three operating segments: Seniors Housing Operating, Triple-net and Outpatient Medical. Our Seniors Housing Operating properties include seniors apartments, assisted living, independent living/continuing care retirement communities, independent supportive living communities (Canada), care homes with and without nursing (U.K.) and combinations thereof that are owned and/or operated through RIDEA structures (see Note 19). Our Triple-net properties include the property types described above as well as long-term/post-acute care facilities. Under the Triple-net segment, we invest in seniors housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our Outpatient Medical properties are typically leased to multiple tenants and generally require a certain level of property management by us.
We evaluate performance based upon consolidated NOI of each segment. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. We believe NOI provides investors relevant and useful information as it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.
Non-segment revenue consists mainly of interest income on certain non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate offices and equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining NOI.
The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019). The results of operations for all acquisitions described in Note 3 are included in our consolidated results of operations from the acquisition dates and are components of the appropriate segments. There are no intersegment sales or transfers.
23

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Summary information for the reportable segments (which excludes unconsolidated entities) is as follows (in thousands):
Three Months Ended June 30, 2020: Seniors Housing Operating Triple-net Outpatient Medical Non-segment / Corporate Total
Resident fees and services $ 769,560 $ $ $ $ 769,560
Rental income 217,492 178,813 396,305
Interest income 88 15,520 461 16,069
Other income 4,002 607 1,557 375 6,541
Total revenues 773,650 233,619 180,831 375 1,188,475
Property operating expenses 595,513 13,563 51,688 660,764
Consolidated net operating income 178,137 220,056 129,143 375 527,711
Depreciation and amortization 139,163 58,138 68,070 265,371
Interest expense 14,029 2,746 4,326 105,256 126,357
General and administrative expenses 34,062 34,062
Loss (gain) on derivatives and financial instruments, net 1,434 1,434
Loss (gain) on extinguishment of debt, net ( 492 ) 741 249
Provision for loan losses 1,451 ( 29 ) 1,422
Impairment of assets 75,151 75,151
Other expenses 5,251 3,500 6,456 4,204 19,411
Income (loss) from continuing operations before income taxes and other items ( 54,965 ) 152,787 49,579 ( 143,147 ) 4,254
Income tax (expense) benefit ( 2,233 ) ( 2,233 )
Income (loss) from unconsolidated entities ( 6,787 ) 6,403 1,716 1,332
Gain (loss) on real estate dispositions, net 14,465 2,148 139,250 155,863
Income (loss) from continuing operations ( 47,287 ) 161,338 190,545 ( 145,380 ) 159,216
Net income (loss) $ ( 47,287 ) $ 161,338 $ 190,545 $ ( 145,380 ) $ 159,216
Total assets $ 14,915,588 $ 9,189,707 $ 7,434,364 $ 1,622,993 $ 33,162,652
Three Months Ended June 30, 2019: Seniors Housing Operating Triple-net Outpatient Medical Non-segment / Corporate Total
Resident fees and services $ 914,085 $ $ $ $ 914,085
Rental income 222,362 163,224 385,586
Interest income 17,118 238 17,356
Other income 1,444 1,278 ( 97 ) 454 3,079
Total revenues 915,529 240,758 163,365 454 1,320,106
Property operating expenses 637,317 12,823 50,987 701,127
Consolidated net operating income 278,212 227,935 112,378 454 618,979
Depreciation and amortization 136,551 56,056 55,445 248,052
Interest expense 17,572 3,225 3,386 117,153 141,336
General and administrative expenses 33,741 33,741
Loss (gain) on derivatives and financial instruments, net 1,913 1,913
Impairment of assets ( 940 ) 10,879 9,939
Other expenses 11,857 5,560

( 4 ) 4,215 21,628
Income (loss) from continuing operations before income taxes and other items 112,232 162,121 42,672 ( 154,655 ) 162,370
Income tax (expense) benefit ( 1,599 ) ( 1,599 )
Income (loss) from unconsolidated entities ( 17,453 ) 6,578 1,826 ( 9,049 )
Gain (loss) on real estate dispositions, net ( 550 ) ( 1,130 ) ( 2 ) ( 1,682 )
Income (loss) from continuing operations 94,229 167,569 44,496 ( 156,254 ) 150,040
Net income (loss) $ 94,229 $ 167,569 $ 44,496 $ ( 156,254 ) $ 150,040
24

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Six Months Ended June 30, 2020 Seniors Housing Operating Triple-net Outpatient Medical Non-segment / Corporate Total
Resident fees and services $ 1,619,532 $ $ $ $ 1,619,532
Rental income 408,877 377,388 786,265
Interest income 192 30,191 927 31,310
Other income 5,054 2,280 1,845 791 9,970
Total revenues 1,624,778 441,348 380,160 791 2,447,077
Property operating expenses 1,203,384 26,865 112,296 1,342,545
Consolidated net operating income 421,394 414,483 267,864 791 1,104,532
Depreciation and amortization 285,937 115,832 138,403 540,172
Interest expense 30,463 5,598 9,134 223,169 268,364
General and administrative expenses 69,543 69,543
Loss (gain) on derivatives and financial instruments, net 9,085 9,085
Loss (gain) on extinguishment of debt, net ( 492 ) 741 249
Provision for loan losses 8,523 ( 29 ) 8,494
Impairment of assets 78,646 24,332 102,978
Other expenses 8,240 4,013 7,463 5,987 25,703
Income (loss) from continuing operations before income taxes and other items 18,600 247,100 112,152 ( 297,908 ) 79,944
Income tax (expense) benefit ( 7,675 ) ( 7,675 )
Income (loss) from unconsolidated entities ( 17,811 ) 12,199 3,252 ( 2,360 )
Gain (loss) on real estate dispositions, net 14,316 51,785 352,586 418,687
Income (loss) from continuing operations 15,105 311,084 467,990 ( 305,583 ) 488,596
Net income (loss) $ 15,105 $ 311,084 $ 467,990 $ ( 305,583 ) $ 488,596

Six Months Ended June 30, 2019 Seniors Housing Operating Triple-net Outpatient Medical Non-segment / Corporate Total
Resident fees and services $ 1,782,370 $ $ $ $ 1,782,370
Rental income 454,394 312,276 766,670
Interest income 32,064 411 32,475
Other income 5,545 2,541 139 2,611 10,836
Total revenues 1,787,915 488,999 312,826 2,611 2,592,351
Property operating expenses 1,245,003 27,778 99,153 1,371,934
Consolidated net operating income 542,912 461,221 213,673 2,611 1,220,417
Depreciation and amortization 268,126 117,404 106,454 491,984
Interest expense 35,823 6,665 6,734 237,346 286,568
General and administrative expenses 69,023 69,023
Loss (gain) on derivatives and financial
instruments, net
( 574 ) ( 574 )
Loss (gain) on extinguishment of debt, net 15,719 15,719
Provision for loan losses 18.69 18,690 18.69 18,690
Impairment of assets ( 940 ) 10,879 9,939
Other expenses 14,803 8,589 750 6,242 30,384
Income (loss) from continuing operations before income taxes and other items 224,160 311,387 88,856 ( 325,719 ) 298,684
Income tax (expense) benefit ( 3,821 ) ( 3,821 )
Income (loss) from unconsolidated entities ( 34,033 ) 12,236 3,549 ( 18,248 )
Gain (loss) on real estate dispositions, net ( 710 ) 166,444 ( 7 ) 165,727
Income (loss) from continuing operations 189,417 490,067 92,398 ( 329,540 ) 442,342
Net income (loss) $ 189,417 $ 490,067 $ 92,398 $ ( 329,540 ) $ 442,342


25

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
Our portfolio of properties and other investments are located in the United States, the United Kingdom and Canada. Revenues and assets are attributed to the country in which the property is physically located. The following is a summary of geographic information for the periods presented (dollars in thousands):
Three Months Ended Six Months Ended
June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019
Revenues:
Amount (1)
% Amount %
Amount (1)
% Amount %
United States $ 973,772 81.9 % $ 1,092,376 82.8 % $ 2,001,553 81.8 % $ 2,136,042 82.4 %
United Kingdom 109,437 9.2 % 112,647 8.5 % 227,319 9.3 % 225,065 8.7 %
Canada 105,266 8.9 % 115,083 8.7 % 218,205 8.9 % 231,244 8.9 %
Total $ 1,188,475 100.0 % $ 1,320,106 100.0 % $ 2,447,077 100.0 % $ 2,592,351 100.0 %
As of
June 30, 2020 December 31, 2019
Assets: Amount % Amount %
United States $ 27,655,745 83.4 % $ 27,513,911 82.4 %
United Kingdom 3,175,033 9.6 % 3,405,388 10.2 %
Canada 2,331,874 7.0 % 2,461,452 7.4 %
Total $ 33,162,652 100.0 % $ 33,380,751 100.0 %
(1) The United States, United Kingdom and Canada represent 77 %, 10 % and 13 %, respectively, of our resident fees and services revenue stream for the three and six months ended June 30, 2020.
19. Income Taxes and Distributions
We elected to be taxed as a REIT commencing with our first taxable year. To qualify as a REIT for federal income tax purposes, at least 90% of taxable income (excluding 100% of net capital gains) must be distributed to stockholders. REITs that do not distribute a certain amount of taxable income in the current year are also subject to a 4% federal excise tax. The main differences between undistributed net income for federal income tax purposes and financial statement purposes are the recognition of straight-line rent for reporting purposes, basis differences in acquisitions, recording of impairments, differing useful lives and depreciation and amortization methods for real property and the provision for loan losses for reporting purposes versus bad debt expense for tax purposes.
Under the provisions of the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”), for taxable years beginning after July 30, 2008, a REIT may lease “qualified health care properties” on an arm’s-length basis to a taxable REIT subsidiary (“TRS”) if the property is operated on behalf of such TRS by a person who qualifies as an “eligible independent contractor”. Generally, the rent received from the TRS will meet the related party rent exception and will be treated as “rents from real property”. A “qualified health care property” includes real property and any personal property that is, or is necessary or incidental to the use of, a hospital, nursing facility, assisted living facility, congregate care facility, qualified continuing care facility, or other licensed facility which extends medical or nursing or ancillary services to patients. We have entered into various joint ventures that were structured under RIDEA. Resident level rents and related operating expenses for these facilities are reported in the unaudited consolidated financial statements and are subject to federal and state income taxes as the operations of such facilities are included in TRS entities. Certain net operating loss carryforwards could be utilized to offset taxable income in future years.
Income taxes reflected in the financial statements primarily represents U.S. federal, state and local income taxes as well as non-U.S. income based or withholding taxes on certain investments located in jurisdictions outside the U.S. The provision for income taxes for the six months ended June 30, 2020 and 2019, was primarily due to operating income or losses, offset by certain discrete items at our TRS entities. In 2014, we established certain wholly-owned direct and indirect subsidiaries in Luxembourg and Jersey and transferred interests in certain foreign investments into this holding company structure. The structure includes a property holding company that is tax resident in the United Kingdom. No material adverse current tax consequences in Luxembourg, Jersey or the United Kingdom resulted from the creation of this holding company structure and most of the subsidiary entities in the structure are treated as disregarded entities of the company for U.S. federal income tax purposes. Subsequent to 2014 we transferred certain subsidiaries to the United Kingdom, while some wholly-owned direct and indirect subsidiaries remain in Luxembourg and Jersey. The company reflects current and deferred tax liabilities for any such withholding taxes incurred from this holding company structure in its consolidated financial statements. Generally, given current statutes of limitations, we are subject to audit by the foreign, federal, state and local taxing authorities under applicable local laws.
26

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
On March 27, 2020, the President of the United States signed the Coronavirus Aid Relief, and Economic Security Act (“CARES Act”) into law. The CARES Act, among its economic stimulus provisions, includes a number of tax provisions relating to refundable payroll tax credits, deferment of employer side social security payments, net operating loss carrybacks, alternative minimum tax credit refunds, modifications to the net interest deduction limitations and technical corrections to tax depreciation methods for qualified improvement property. Certain of these provisions may impact the provision for taxes in our consolidated financial statements, including in particular the provision allowing for the carryback of net operating losses which would be applicable to our TRSs. We have made a reasonable estimate of the tax impact to us of the CARES Act in our consolidated financial statements, and while we do not believe that there will be further material impacts to the consolidated financial statements related to the CARES Act tax provisions, we will continue to evaluate the impact of the CARES Act and any guidance provided by the U.S. Treasury and the IRS on our consolidated financial statements. It is possible our estimates could differ materially from the actual tax impact to us of the CARES Act.
20. Variable Interest Entities
We have entered into joint ventures to own certain seniors housing and outpatient medical assets which are deemed to be VIEs. We have concluded that we are the primary beneficiary of these VIEs based on a combination of operational control of the joint venture and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Except for capital contributions associated with the initial joint venture formations, the joint ventures have been and are expected to be funded from the ongoing operations of the underlying properties. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs in the aggregate (in thousands):
June 30, 2020 December 31, 2019
Assets:
Net real estate investments $ 457,107 $ 960,093
Cash and cash equivalents 30,438 27,522
Receivables and other assets 12,596 14,586
Total assets (1)
$ 500,141 $ 1,002,201
Liabilities and equity:
Secured debt $ 166,567 $ 460,117
Lease liabilities 1,326 1,326
Accrued expenses and other liabilities 14,810 22,215
Total equity 317,438 518,543
Total liabilities and equity $ 500,141 $ 1,002,201
(1) Note that assets of the consolidated VIEs can only be used to settle obligations relating to such VIEs. Liabilities of the consolidated VIEs represent claims against the specific assets of the VIEs.
27

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
EXECUTIVE SUMMARY
Company Overview
Business Strategy
Key Transactions
Key Performance Indicators, Trends and Uncertainties
Corporate Governance
LIQUIDITY AND CAPITAL RESOURCES
Sources and Uses of Cash
Off-Balance Sheet Arrangements
Contractual Obligations
Capital Structure
RESULTS OF OPERATIONS
Summary
Seniors Housing Operating
Triple-net
Outpatient Medical
Non-Segment/Corporate
OTHER
Non-GAAP Financial Measures
Critical Accounting Policies
Cautionary Statement Regarding Forward-Looking Statements
28

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis is based primarily on the unaudited consolidated financial statements of Welltower Inc. for the periods presented and should be read together with the notes thereto contained in this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2019, including factors identified under the headings “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” References herein to “we,” “us,” “our,” or the “Company” refer to Welltower Inc. and its subsidiaries unless specifically noted otherwise.
Executive Summary
Company Overview
Welltower Inc. (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower™, a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (U.S.), Canada and the United Kingdom (U.K.), consisting of seniors housing and post-acute communities and outpatient medical properties.
The following table summarizes our consolidated portfolio for the three months ended June 30, 2020 (dollars in thousands):
Percentage of Number of
Type of Property
NOI (1)
NOI Properties
Seniors Housing Operating $ 178,137 33.8 % 526
Triple-net 220,056 41.7 % 653
Outpatient Medical 129,143 24.5 % 347
Totals $ 527,336 100.0 % 1,526
(1) Represents consolidated NOI and excludes our share of investments in unconsolidated entities. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount. See Non-GAAP Financial Measures for additional information and reconciliation.
The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of the pandemic, the actions taken to contain the pandemic or mitigate its impact and the direct and indirect economic effects of the pandemic and containment measures, among others. The COVID-19 pandemic could have material and adverse effects on our financial condition, results of operations and cash flows in the future.
Our Seniors Housing Operating revenues are dependent on occupancy. While admission bans were lifted across our portfolio during the second quarter and in July, move-out activity continued to outpace move-ins, resulting in occupancy losses throughout the period. Further occupancy losses are expected in the third quarter as move-out activity continues to exceed move-ins, but to a lesser degree than experienced in the second quarter.
We have incurred increased operational costs as a result of the introduction of public health measures and other regulations affecting our properties, as well as additional health and safety measures adopted by us and our operators related to the COVID-19 pandemic, including increases in labor and property cleaning expenses and expenditures related to our efforts to procure PPE and supplies. We expect total Seniors Housing Operating expenses to remain elevated during the pandemic and potentially beyond as these additional health and safety measures become standard practice.
Our Triple-net operators are experiencing similar occupancy declines and operating costs as described above with respect to our Seniors Housing Operating properties. However, long-term/post-acute care facilities are generally experiencing a higher degree of occupancy declines. These factors may continue to impact the ability of our Triple-net operators to make contractual rent payments to us in the future. Many of our Triple-net operators received funds under the Coronavirus Aid Relief, and Economic Security Act (“CARES Act”) and operators of long-term/post-acute care facilities have also received funds under the CARES Act Provider Relief Fund. Accordingly, collection of Triple-net rent due during the COVID-19 pandemic to date (from March to July) has been consistent with historical collection rates and no significant rent concessions or deferrals have been made.
Our Outpatient Medical tenants are experiencing temporary medical practice closures or decreases in revenue due to government imposed restrictions on elective medical procedures, stay at home orders or decisions by patients to delay treatments which may continue to adversely affect their ability to make contractual rent payments. These factors have and may continue to cause operators or tenants to seek modifications of such obligations, resulting in reductions in revenue and increases in uncollectible receivables. We will evaluate each request on a case-by-case basis and determine if a form of rent relief is warranted following an examination of the tenant’s financial health, rent coverage, current operating situation and other factors.
29

WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

We have either collected or approved short term deferrals for over 99 % of Outpatient Medical rent due in the second quarter, consisting of 87 % cash collections and 12 % of short term deferrals. In most cases, the deferred rent respresents two months of rent with expected repayment by the end of the year. Approximately 98 % of Outpatient Medical rent due in July was either collected or aproved for short term deferral, with cash collections accelerating to approximately 95 %. Short term deferrals of July rent decreased to 3 %, which primarily relates to tenants in local jurisdictions for which relief was mandated. Furthermore, collections of deferred rent due in June and July under executed deferrals were 96 %. To the extent that deferred rent is not repaid as expected, or the prolonged impact of the COVID-19 pandemic causes operators or tenants to seek further modifications of their lease agreements, we may recognize reductions in revenue and increases in uncollectible receivables.
As a result of uncertainty regarding the length and severity of the COVID-19 pandemic and the impact of the pandemic on our business and related industries, our investments in and acquisitions of senior housing and health care properties, as well as our ability to transition or sell properties with profitable results, may be limited. We have a significant development portfolio as of June 30, 2020. To date we have only experienced minor construction and licensing delays with respect to our development portfolio, but may experience more significant delays in the future. Such disruptions to acquisition, disposition and development activity may negatively impact our long-term competitive position.
Business Strategy
Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in NOI and portfolio growth. To meet these objectives, we invest across the full spectrum of seniors housing and health care real estate and diversify our investment portfolio by property type, relationship and geographic location.
Substantially all of our revenues are derived from operating lease rentals, resident fees and services and interest earned on outstanding loans receivable. These items represent our primary sources of liquidity to fund distributions and depend upon the continued ability of our obligors to make contractual rent and interest payments to us and the profitability of our operating properties. To the extent that our obligors/partners experience operating difficulties and become unable to generate sufficient cash to make payments or operating distributions to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property. Our asset management process for seniors housing properties generally includes review of monthly financial statements and other operating data for each property, review of obligor/partner creditworthiness, property inspections and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. Our internal property management division manages and monitors the outpatient medical portfolio with a comprehensive process including review of tenant relations, lease expirations, the mix of health service providers, hospital/health system relationships, property performance, capital improvement needs and market conditions among other things. We evaluate the operating environment in each property’s market to determine the likely trend in operating performance of the facility. When we identify unacceptable trends, we seek to mitigate, eliminate or transfer the risk. Through these efforts, we generally aim to intervene at an early stage to address any negative trends, and in so doing, support both the collectability of revenue and the value of our investment.
In addition to our asset management and research efforts, we also aim to structure our relevant investments to mitigate payment risk. Operating leases and loans are normally credit enhanced by guarantees and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other real estate loans, operating leases or agreements between us and the obligor and its affiliates.
For the six months ended June 30, 2020, resident fees and services and rental income represented 66% and 32%, respectively, of total revenues. Substantially all of our operating leases are designed with escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectability assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.
Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses and general and administrative expenses. Depending upon the availability and cost of external capital, we believe our liquidity is sufficient to fund these uses of cash.

30

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
We also continuously evaluate opportunities to finance future investments. New investments are generally funded from temporary borrowings under our unsecured revolving credit facility and commercial paper program, internally generated cash and the proceeds from investment dispositions. Our investments generate cash from NOI and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under our unsecured revolving credit facility and commercial paper program, has historically been provided through a combination of the issuance of public debt and equity securities and the incurrence or assumption of secured debt.
Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. It is also likely that investment dispositions may occur in the future. To the extent that investment dispositions exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any investment dispositions in new investments. To the extent that new investment requirements exceed our available cash on-hand, we expect to borrow under our unsecured revolving credit facility and commercial paper program. At June 30, 2020, we h ad $1,678,770,000 of cash and cash equivalents, $147,473,000 of restricted cash and $3,000,000,000 of available borrowing capacity under our unsecured revolving credit facility.
Key Transactions
Capital The foll owing summarizes key capital transaction that occurred during the six months ended June 30, 2020 and subsequent events:
During the six months ended June 30, 2020, we extinguished $314,631,000 of secured debt at a blended average interest rate of 2.94%.
During the six months ended June 30, 2020, we sold 2,128,000 shares of common stock under our ATM and DRIP programs, via both cash settle and forward sale agreements, generating gross proceeds of approximately $175,484,000. The sale of these shares and settlement of previously outstanding forward sales resulted in gross proceeds of approximately $607,177,000 which were used to reduce borrowings under our unsecured revolving credit facility.
In April, we closed on our previously announced $1.0 billion two-year unsecured term loan. The term loan bears interest at a rate of 1-month LIBOR + 1.20%, based on our credit rating.
On June 30, 2020, we completed the issuance of $600 million senior unsecured notes bearing interest at 2.75% with a maturity date of January 2031. Net proceeds were used to fund tender offers for $426,000,000 of our 3.75% senior unsecured notes due 2023 and our 3.95% senior unsecured notes due 2023 which settled on July 1, 2020. The remaining proceeds were used to reduce borrowings under our term loan by $140 million.
Investments The following summarizes our property acquisitions and joint venture investments completed during the six months ended June 30, 2020 (dollars in thousands):
Properties
Investment Amount (1)
Capitalization Rates (2)
Book Amount (3)
Seniors Housing Operating 6 $ 168,725 4.9 % $ 159,048
Triple-net (4)
% 765
Outpatient Medical 16 235,387 6.1 % 236,127
Totals 22 $ 404,112 5.6 % $ 395,940
(1) Represents stated pro rata purchase price including cash and any assumed debt but excludes fair value adjustments pursuant to U.S. GAAP.
(2) Represents annualized contractual or projected net operating income to be received in cash divided by investment amounts.
(3) Represents amounts recorded in net real estate investments including fair value adjustments pursuant to U.S. GAAP. See Note 3 to our unaudited consolidated financial statements for additional information.
(4) Represents the acquisition of a condo unit at a previously acquired property.
Dispositions The following summarizes property dispositions completed during the six months ended June 30, 2020 (dollars in thousands):
31

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Properties
Proceeds (1)
Capitalization Rates (2)
Book Amount (3)
Seniors Housing Operating 13 $ 498,510 5.6 % $ 706,964
Triple-net 5 70,439 5.0 % 33,445
Outpatient Medical 55 1,088,250 5.6 % 808,992
Totals 73 $ 1,657,199 5.5 % $ 1,549,401
(1) Represents pro rata proceeds received upon disposition including any seller financing.
(2) Represents annualized contractual income that was being received in cash at date of disposition divided by disposition proceeds.
(3) Represents carrying value of net real estate assets at time of disposition. See Note 5 to our unaudited consolidated financial statements for additional information.
Dividends Our Board of Directors declared a cash dividend for the quarter ended June 30, 2020 of $0.61 per share. On August 27, 2020, we will pay our 197 th consecutive quarterly cash dividend to stockholders of record on August 18, 2020.

Key Performance Indicators, Trends and Uncertainties
We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, credit strength and concentration risk. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.
Operating Performance We believe that net income and net income attributable to common stockholders (“NICS”) per the Consolidated Statements of Comprehensive Income are the most appropriate earnings measures. Other useful supplemental measures of our operating performance include funds from operations attributable to common stockholders (“FFO”) and consolidated net operating income (“NOI”); however, these supplemental measures are not defined by U.S. generally accepted accounting principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations. These earnings measures are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies. The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands):
Three Months Ended
June 30, March 31, December 31, September 30, June 30, March 31,
2020 2020 2019 2019 2019 2019
Net income (loss) $ 159,216 $ 329,380 $ 240,136 $ 647,932 $ 150,040 $ 292,302
NICS 179,246 310,284 224,324 589,876 137,762 280,470
FFO 335,597 356,124 476,298 352,378 390,021 358,383
NOI 527,711 576,821 600,302 610,545 618,979 601,438
Credit Strength We measure our credit strength both in terms of leverage ratios and coverage ratios. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt, net of cash and Internal Revenue Code section 1031 deposits. The coverage ratios indicate our ability to service interest and fixed charges (interest, secured debt principal amortization and preferred dividends). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain a capital structure consistent with our current profile. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliation of these measures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented:
Three Months Ended
June 30, March 31, December 31, September 30, June 30, March 31,
2020 2020 2019 2019 2019 2019
Net debt to book capitalization ratio 43% 44% 46% 45% 48% 43%
Net debt to undepreciated book capitalization ratio 35% 37% 39% 38% 41% 36%
Net debt to market capitalization ratio 36% 40% 30% 26% 30% 28%
Interest coverage ratio 4.29x 5.42x 4.64x 7.61x 3.74x 4.80x
Fixed charge coverage ratio 3.84x 4.88x 4.20x 6.96x 3.42x 4.38x
32

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Concentration Risk We evaluate our concentration risk in terms of NOI by property mix, relationship mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our NOI could be at risk if certain sectors were to experience downturns. Property mix measures the portion of our NOI that relates to our various property types. Relationship mix measures the portion of our NOI that relates to our current top five relationships. Geographic mix measures the portion of our NOI that relates to our current top five states (or international equivalents). The following table reflects our recent historical trends of concentration risk by NOI for the periods indicated below:
Three Months Ended
June 30, March 31, December 31, September 30, June 30, March 31,
2020 2020 2019 2019 2019 2019
Property mix: (1)
Seniors Housing Operating 34% 42% 40% 42% 45% 44%
Triple-net 42% 34% 38% 38% 37% 39%
Outpatient Medical 24% 24% 22% 20% 18% 17%
Relationship mix: (1)
Sunrise Senior Living (2)
10% 14% 14% 14% 14% 15%
ProMedica 10% 9% 9% 9% 9% 9%
Genesis Healthcare 6% 5% 5% 5% 5% 5%
Revera (2)
5% 6% 6% 6% 6% 6%
Avery Healthcare 3% 3% 3% 3% 3% 3%
Remaining relationships 66% 63% 63% 63% 63% 62%
Geographic mix: (1)
California 14% 15% 13% 14% 13% 13%
Texas 10% 7% 9% 8% 8% 8%
United Kingdom 8% 9% 9% 8% 8% 9%
New Jersey 7% 8% 8% 7% 7% 7%
Pennsylvania 6% 6% 6% 6% 6% 6%
Remaining geographic areas 55% 55% 55% 57% 58% 57%
(1) Excludes our share of investments in unconsolidated entities and non-segment/corporate NOI. Entities in which we have a joint venture with a minority partner are shown at 100% of the joint venture amount.
(2) Revera owns a controlling interest in Sunrise Senior Living.
Lease Expirations The following table sets forth information regarding lease expirations for certain portions of our portfolio as of June 30, 2020 (dollars in thousands):
Expiration Year (1)
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 Thereafter
Triple-net:
Properties 3 7 6 2 4 48 76 18 15 15 440
Base rent (2)
$ 52 $ 12,511 $ 6,407 $ 840 $ 11,262 $ 54,270 $ 104,023 $ 35,406 $ 22,446 $ 30,479 $ 495,098
% of base rent % 1.6 % 0.8 % 0.1 % 1.5 % 7.0 % 13.5 % 4.6 % 2.9 % 3.9 % 64.1 %
Units/beds 220 1,316 757 1,337 692 3,033 6,078 2,350 1,633 1,429 45,632
% of Units/beds 0.3 % 2.0 % 1.2 % 2.1 % 1.1 % 4.7 % 9.4 % 3.6 % 2.5 % 2.2 % 70.9 %
Outpatient Medical:
Square feet 1,454,125 1,562,375 1,975,098 2,018,860 2,059,566 1,180,994 1,147,542 1,069,560 907,508 807,202 5,700,539
Base rent (2)
$ 39,595 $ 45,979 $ 55,886 $ 54,605 $ 61,819 $ 32,382 $ 32,063 $ 27,593 $ 24,511 $ 22,241 $ 133,024
% of base rent 7.5 % 8.7 % 10.6 % 10.3 % 11.7 % 6.1 % 6.1 % 5.2 % 4.6 % 4.2 % 25.0 %
Leases 318 377 399 411 341 235 155 144 114 88 199
% of Leases 11.4 % 13.6 % 14.3 % 14.8 % 12.3 % 8.5 % 5.6 % 5.2 % 4.1 % 3.2 % 7.0 %
(1) Excludes investments in unconsolidated entities, developments, land parcels, loans receivable and sub-leases. Investments classified as held for sale are included in the current year.
(2) The most recent monthly cash base rent annualized. Base rent does not include tenant recoveries or amortization of above and below market lease intangibles or other non-cash income.
We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Cautionary Statement Regarding Forward-Looking Statements” and other sections of this Quarterly Report on Form 10-Q. Management
33

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2019, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of these risk factors.
Corporate Governance
Maintaining investor confidence and trust is important in today’s business environment. Our Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on the Internet at www.welltower.com/investors/governance. The information on our website is not incorporated by reference in this Quarterly Report on Form 10-Q, and our web address is included as an inactive textual reference only.
Liquidity and Capital Resources
Sources and Uses of Cash
Our primary sources of cash include resident fees and services, rent and interest receipts, borrowings under our unsecured revolving credit facility and commercial paper program, public issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures, construction advances and transaction costs), loan advances, property operating expenses and general and administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below. The following is a summary of our sources and uses of cash flows for the periods presented (dollars in thousands):
Six Months Ended Change
June 30, 2020 June 30, 2019 $ %
Cash, cash equivalents and restricted cash at beginning of period $ 385,766 $ 316,129 $ 69,637 22 %
Cash provided from (used in) operating activities 811,616 854,482 (42,866) -5 %
Cash provided from (used in) investing activities 1,142,180 (2,531,364) 3,673,544 145 %
Cash provided from (used in) financing activities (504,309) 1,720,804 (2,225,113) -129 %
Effect of foreign currency translation (9,010) (333) (8,677) -2,606 %
Cash, cash equivalents and restricted cash at end of period $ 1,826,243 $ 359,718 $ 1,466,525 408 %
Operating Activities The changes in net cash provided from operating activities are primarily attributable to declines in revenue and increases in property operating expenses, as well as the impact of short-term rent deferrals granted as a result of the COVID-19 pandemic in 2020. Please see “Results of Operations” for discussion of net income fluctuations. For the six months ended June 30, 2020 and 2019 , cash flows provided from operations exceeded cash distributions to stockholders.
Investing Activities The changes in net cash provided from/used in investing activities are primarily attributable to net changes in real property investments and dispositions, loans receivable and investments in unconsolidated entities, which are summarized above in “Key Transactions” and Notes 3 and 5 of our unaudited consolidated financial statements. The following is a summary of cash used in non-acquisition capital improvement activities for the periods presented (dollars in thousands):
Six Months Ended Change
June 30, 2020 June 30, 2019 $
New development $ 93,031 $ 155,409 $ (62,378)
Recurring capital expenditures, tenant improvements and lease commissions 40,939 49,925 (8,986)
Renovations, redevelopments and other capital improvements 81,164 74,251 6,913
Total $ 215,134 $ 279,585 $ (64,451)
34

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The change in new development is primarily due to the number and size of construction projects on-going during the relevant periods. Renovations, redevelopments and other capital improvements include expenditures to maximize property value, increase net operating income, maintain a market-competitive position and/or achieve property stabilization.
Financing Activities The changes in net cash provided from/used in financing activities are primarily attributable to changes related to our long-term debt arrangements, the issuances of common stock and dividend payments which are summarized above in "Key Transactions". Please refer to Notes 10, 11 and 14 of our unaudited consolidated financial statements for additional information.
On April 1, 2020, in response to uncertain financial market conditions arising from the COVID-19 pandemic, we undertook steps to strengthen our balance sheet and to enhance our liquidity by entering into a $1.0 billion two-year unsecured term loan. Additionally, on June 30, 2020, we completed the issuance of $600 million senior unsecured notes with a maturity date of January 2031. Net proceeds were used to fund tender offers for $426 million of our 3.75% senior unsecured notes due 2023 and our 3.95% senior unsecured notes due 2023, which settled on July 1, 2020. The remaining proceeds were used to reduce borrowings under the term loan by $140 million. After consideration of these transactions, we have total near-term available liquidity of approximately $4.2 billion at July 2, 2020. However, we are unable to accurately predict the full impact that the pandemic will have on our results from operations, financial condition, liquidity and cash flows due to numerous factors discussed in Part II Item 1A. Risk Factors.
Off-Balance Sheet Arrangements
At June 30, 2020, we had investments in unconsolidated entities with our ownership generally ranging from 10% to 50%. We use financial derivative instruments to hedge interest rate and foreign currency exchange rate exposure. At June 30, 2020, we had 8 outstanding letter of credit obligations. Please see Notes 8, 12 and 13 to our unaudited consolidated financial statements for additional information.
Contractual Obligations
The following table summarizes our payment requirements under contractual obligations as of June 30, 2020 (in thousands):
Payments Due by Period
Contractual Obligations Total 2020 2021-2022 2023-2024 Thereafter
Unsecured credit facility and commercial paper (1,2)
$ $ $ $ $
Senior unsecured notes and term credit facilities: (2)
U.S. Dollar senior unsecured notes 8,700,000 2,450,000 6,250,000
Canadian Dollar senior unsecured notes (3)
220,345 220,345
Pounds Sterling senior unsecured notes (3)
1,298,745 1,298,745
U.S. Dollar term credit facility 1,510,000 1,010,000 500,000
Canadian Dollar term credit facility (3)
183,621 183,621
Secured debt: (2,3)
Consolidated 2,627,989 257,139 872,088 503,754 995,008
Unconsolidated 929,033 33,470 83,834 111,479 700,250
Contractual interest obligations: (4)
Unsecured credit facility and commercial paper
Senior unsecured notes and term loans (3)
4,092,526 242,199 859,915 752,916 2,237,496
Consolidated secured debt (3)
354,990 39,429 127,559 74,731 113,271
Unconsolidated secured debt (3)
204,105 15,786 59,337 54,025 74,957
Financing lease liabilities (5)
199,117 4,602 17,076 70,802 106,637
Operating lease liabilities (5)
1,067,950 11,097 43,018 40,915 972,920
Purchase obligations (6)
563,822 289,239 210,622 50,413 13,548
Total contractual obligations $ 21,952,243 $ 892,961 $ 3,283,449 $ 4,792,656 $ 12,983,177
(1) Relates to our unsecured credit facility and commercial paper with an aggregate commitment of $3,000,000,000. See Note 10 to our unaudited consolidated financial statements for additional information.
(2) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.
(3) Based on foreign currency exchange rates in effect as of balance sheet date.
(4) Based on variable interest rates in effect as of balance sheet date.
(5) See Note 6 to our unaudited consolidated financial statements for additional information.
(6) See Note 13 to our unaudited consolidated financial statements for additional information.
35

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Capital Structure
Please refer to “Credit Strength” above for a discussion of our leverage and coverage ratio trends. Our debt agreements contain various covenants, restrictions and events of default. Certain agreements require us to maintain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2020, we were in compliance with all of the covenants under our debt agreements. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings. However, under our primary unsecured credit facility, the ratings on our senior unsecured notes are used to determine the fees and interest charged. We plan to manage the company to maintain compliance with our debt covenants and with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the rating agencies could have a material adverse impact on our cost and availability of capital, which could have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.
On May 17, 2018, we filed with the Securities and Exchange Commission (1) an open-ended automatic or “universal” shelf registration statement covering an indeterminate amount of future offerings of debt securities, common stock, preferred stock, depositary shares, warrants and units and (2) a registration statement in connection with our enhanced dividend reinvestment plan (“DRIP”) under which we may issue up to 15,000,000 shares of common stock. As o f July 31, 2020, 2,541,750 shares of common stock remained available for issuance under the DRIP registration statement. On February 25, 2019, we entered into separate amended and restated equity distribution agreements with each of Barclays Capital Inc., Citigroup Global Markets Inc., Credit Agricole Securities (USA) Inc., Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Morgan Stanley & Co. LLC, MUFG Securities Americas Inc., RBC Capital Markets, LLC, UBS Securities LLC and Wells Fargo Securities, LLC relating to the offer and sale from time to time of up to $1,500,000,000 aggregate amount of our common stock (“Equity Shelf Program”). The Equity Shelf Program also allows us to enter into forward sale agreements. As of July 31, 2020, we had $499,341,000 of remaining capacity under the Equity Shelf Program and there were no outstanding forward sales agreements. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our unsecured revolving credit facility and commercial paper program.
Results of Operations
Summary
Our primary sources of revenue include resident fees and services, rent and interest income. Our primary expenses include property operating expenses, depreciation and amortization, interest expense, general and administrative expenses and other expenses. We evaluate our business and make resource allocations on our three business segments: Seniors Housing Operating, Triple-net and Outpatient Medical. The primary performance measures for our properties are NOI and same store NOI ("SSNOI"), and other supplemental measures include FFO and Adjusted EBITDA, which are further discussed below. Please see Non-GAAP Financial Measures for additional information and reconciliations. The following is a summary of our results of operations (dollars in thousands, except per share amounts):
Three Months Ended Change Six Months Ended Change
June 30, June 30, June 30, June 30,
2020 2019 Amount % 2020 2019 Amount %
Net income $ 159,216 $ 150,040 $ 9,176 6 % $ 488,596 $ 442,342 $ 46,254 10 %
NICS 179,246 137,762 41,484 30 % 489,530 418,232 71,298 17 %
FFO 335,597 390,021 (54,424) -14 % 691,721 748,404 (56,683) -8 %
EBITDA 553,177 541,027 12,150 2 % 1,304,807 1,224,715 80,092 7 %
NOI 527,711 618,979 (91,268) -15 % 1,104,532 1,220,417 (115,885) -9 %
SSNOI 414,280 464,556 (50,276) -11 % 832,325 886,723 (54,398) -6 %
Per share data (fully diluted):
NICS $ 0.42 $ 0.34 $ 0.08 24 % $ 1.17 $ 1.05 $ 0.13 12 %
FFO $ 0.80 $ 0.96 $ (0.16) -17 % $ 1.66 $ 1.87 $ (0.21) -11 %
Interest coverage ratio 4.29 x 3.74 x 0.55 x 15 % 4.88 x 4.27 x 0.61 x 14 %
Fixed charge coverage ratio 3.84 x 3.42 x 0.42 x 12 % 4.37 x 3.90 x 0.47 x 12 %
Seniors Housing Operating
The following is a summary of our SSNOI at Welltower's Share for the Seniors Housing Operating segment (dollars in thousands):
36

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
QTD Pool YTD Pool
Three Months Ended Change Six Months Ended Change
June 30, 2020 June 30, 2019 $ % June 30, 2020 June 30, 2019 $ %
SSNOI (1)
$ 163,922 $ 217,562 $ (53,640) -24.7 % $ 336,658 $ 401,141 $ (64,483) -16.1 %
(1) For the three and six months ended June 30, 2020 and 2019, amounts relate to 497 and 416 same store properties, respectively. Please see Non-GAAP Financial Measures for additional information and reconciliations.

The following is a summary of our results of operations for the Seniors Housing Operating segment (dollars in thousands):
Three Months Ended Change Six Months Ended Change
June 30, June 30, June 30, June 30,
2020 2019 $ % 2020 2019 $ %
Revenues:
Resident fees and services
$ 769,560 $ 914,085 $ (144,525) -16 % $ 1,619,532 $ 1,782,370 $ (162,838) -9 %
Interest income
88 88 n/a 192 192 n/a
Other income
4,002 1,444 2,558 177 % 5,054 5,545 (491) -9 %
Total revenues
773,650 915,529 (141,879) -15 % 1,624,778 1,787,915 (163,137) -9 %
Property operating expenses 595,513 637,317 (41,804) -7 % 1,203,384 1,245,003 (41,619) -3 %
NOI (1)
178,137 278,212 (100,075) -36 % 421,394 542,912 (121,518) -22 %
Other expenses:
Depreciation and amortization
139,163 136,551 2,612 2 % 285,937 268,126 17,811 7 %
Interest expense
14,029 17,572 (3,543) -20 % 30,463 35,823 (5,360) -15 %
Loss (gain) on extinguishment of debt, net
(492) (492) n/a (492) (492) n/a
Impairment of assets
75,151 75,151 n/a 78,646 78,646 n/a
Other expenses
5,251 11,857 (6,606) -56 % 8,240 14,803 (6,563) -44 %
233,102 165,980 67,122 40 % 402,794 318,752 84,042 26 %
Income (loss) from continuing operations before income taxes and other items (54,965) 112,232 (167,197) -149 % 18,600 224,160 (205,560) -92 %
Income (loss) from unconsolidated entities (6,787) (17,453) 10,666 61 % (17,811) (34,033) 16,222 48 %
Gain (loss) on real estate dispositions, net 14,465 (550) 15,015 n/a 14,316 (710) 15,026 n/a
Income from continuing operations (47,287) 94,229 (141,516) -150 % 15,105 189,417 (174,312) -92 %
Net income (loss) (47,287) 94,229 (141,516) -150 % 15,105 189,417 (174,312) -92 %
Less: Net income (loss) attributable to noncontrolling interests (26,156) 2,236 (28,392) n/a (28,088) 3,977 (32,065) n/a
Net income (loss) attributable to common stockholders $ (21,131) $ 91,993 $ (113,124) -123 % $ 43,193 $ 185,440 $ (142,247) -77 %
(1) See Non-GAAP Financial Measures below.
Decreases in resident fees and services and property operating expenses are primarily a result of dispositions and decreases in occupancy across the portfolio due to the COVID-19 pandemic. Occupancy within our Seniors Housing Operating portfolio has declined as follows:
February March April May June July
Spot occupancy (1)
85.8 % 85.0 % 82.8 % 81.0 % 80.1 % 79.4 %
Sequential occupancy change (0.8) % (2.2) % (1.8) % (0.9) % (0.7) %
(1) Spot occupancy represents approximate month end occupancy for properties in operation as of February 2020, including unconsolidated properties but excluding acquisitions, dispositions and development conversions since the start of the COVID-19 pandemic.
In addition, we have experienced increased operational costs of $43,058,000 and $50,352,000 during the three and six months ended June 30, 2020 included in property operating expenses as a result of the introduction of public health measures and other regulations affecting our properties, as well as additional health and safety measures adopted by us and our operators related to the COVID-19 pandemic, including increases in labor and property cleaning expenses and expenditures related to our efforts to procure PPE and supplies, net of reimbursements.
The fluctuations in depreciation and amortization are due to acquisitions and dispositions and variations in amortization of short-lived intangible assets. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly.
37

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
During the three months ended March 31, 2020, we recorded impairment charges on one held for use property as the carrying value exceeded the estimated fair value. During the three months ended June 30, 2020, we entered into and subsequently closed a definitive purchase and sale agreement to sell six properties. In conjunction with this transaction, an impairment charge of $56,371,000 was recognized. During the three months ended June 30, 2020, we agreed to terms including pricing for the sale of a portfolio of six properties previously classified as held for sale resulting in an impairment charge of $18,780,000. Transaction costs related to asset acquisitions are capitalized as a component of the purchase price. Changes in the gain on sales of properties are related to the volume and timing of property sales and the sales prices. The decrease in other expenses is primarily due to the decrease of noncapitalizable transaction costs associated with acquisitions and operator transitions.
During the six months ended June 30, 2020, we completed three Seniors Housing Operating construction projects representing $93,188,000 or $300,606 per unit. The following is a summary of our Seniors Housing Operating construction projects, excluding expansions, pending as of June 30, 2020 (dollars in thousands):
Location Units Commitment Balance Est. Completion
Potomac, MD 120 $ 56,720 $ 38,794 4Q20
Beckenham, UK 100 58,258 31,054 3Q21
Barnet, UK 100 63,700 30,839 4Q21
Hendon, UK 102 69,019 36,298 1Q22
422 $ 247,697 136,985
Toronto, ON Project in planning stage 42,866
Brookline, MA Project in planning stage 21,011
Washington, DC Project in planning stage 20,803
$ 221,665
Interest expense represents secured debt interest expense which fluctuates based on the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The following is a summary of our Seniors Housing Operating segment property secured debt principal activity (dollars in thousands):
Three Months Ended Six Months Ended
June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019
Wtd. Avg. Wtd. Avg. Wtd. Avg. Wtd. Avg.
Amount Interest Rate Amount Interest Rate Amount Interest Rate Amount Interest Rate
Beginning balance $ 2,044,926 3.56 % $ 1,995,343 3.79 % $ 2,115,037 3.54 % $ 1,810,587 3.87 %
Debt issued % 48,806 2.94 % 44,921 2.58 % 295,969 3.52 %
Debt assumed % % % 42,000 4.62 %
Debt extinguished (290,198) 2.81 % (36,903) 2.74 % (306,238) 2.90 % (151,473) 4.42 %
Principal payments (11,603) 3.17 % (11,225) 3.49 % (23,776) 3.18 % (22,430) 3.44 %
Foreign currency 36,500 3.01 % 22,159 3.31 % (50,319) 3.19 % 43,527 3.33 %
Ending balance $ 1,779,625 2.91 % $ 2,018,180 3.80 % $ 1,779,625 2.91 % $ 2,018,180 3.80 %
Monthly averages $ 2,009,523 3.17 % $ 1,996,642 3.80 % $ 2,044,995 3.33 % $ 1,950,546 3.82 %
The majority of our Seniors Housing Operating properties are formed through partnership interests. Losses from unconsolidated entities are largely attributable to depreciation and amortization of short-lived intangible assets related to certain investments in unconsolidated joint ventures, as well as the disposal of an investment in an unconsolidated entity during the quarter ended June 30, 2019. Net income attributable to noncontrolling interests represents our partners’ share of net income (loss) related to joint ventures. The decrease during the three months ended June 30, 2020 relates primarily to our partners' share of impairment charges recognized, offset by our partners' share of gains on dispositions.
Triple-net
The following is a summary of our SSNOI at Welltower's Share for the Triple-net segment (dollars in thousands):
QTD Pool YTD Pool
Three Months Ended Change Six Months Ended Change
June 30, 2020 June 30, 2019 $ % June 30, 2020 June 30, 2019 $ %
SSNOI (1)
$ 170,783 $ 169,784 $ 999 0.6 % $ 340,770 $ 334,928 $ 5,842 1.7 %
38

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
(1) For the three and six months ended June 30, 2020 and 2019, amounts relate to 641 and 635 same store properties, respectively. Please see Non-GAAP Financial Measures for additional information and reconciliations.
The following is a summary of our results of operations for the Triple-net segment (dollars in thousands):
Three Months Ended Change Six Months Ended Change
June 30, June 30, June 30, June 30,
2020 2019 $ % 2020 2019 $ %
Revenues:
Rental income
$ 217,492 $ 222,362 $ (4,870) -2 % $ 408,877 $ 454,394 $ (45,517) -10 %
Interest income
15,520 17,118 (1,598) -9 % 30,191 32,064 (1,873) -6 %
Other income
607 1,278 (671) -53 % 2,280 2,541 (261) -10 %
Total revenues
233,619 240,758 (7,139) -3 % 441,348 488,999 (47,651) -10 %
Property operating expenses 13,563 12,823 740 6 % 26,865 27,778 (913) -3 %
NOI (1)
220,056 227,935 (7,879) -3 % 414,483 461,221 (46,738) -10 %
Other expenses:
Depreciation and amortization
58,138 56,056 2,082 4 % 115,832 117,404 (1,572) -1 %
Interest expense
2,746 3,225 (479) -15 % 5,598 6,665 (1,067) -16 %
Loss (gain) on derivatives and financial instruments, net
1,434 1,913 (479) -25 % 9,085 (574) 9,659 n/a
Provision for loan losses
1,451 1,451 n/a 8,523 18,690 (10,167) -54 %
Impairment of assets
(940) 940 100 24,332 (940) 25,272 n/a
Other expenses
3,500 5,560 (2,060) -37 % 4,013 8,589 (4,576) -53 %
67,269 65,814 1,455 2 % 167,383 149,834 17,549 12 %
Income (loss) from continuing operations before income taxes and other items 152,787 162,121 (9,334) -6 % 247,100 311,387 (64,287) -21 %
Income (loss) from unconsolidated entities 6,403 6,578 (175) -3 % 12,199 12,236 (37) %
Gain (loss) on real estate dispositions, net 2,148 (1,130) 3,278 290 % 51,785 166,444 (114,659) -69 %
Income from continuing operations 161,338 167,569 (6,231) -4 % 311,084 490,067 (178,983) -37 %
Net income 161,338 167,569 (6,231) -4 % 311,084 490,067 (178,983) -37 %
Less: Net income (loss) attributable to noncontrolling interests 9,103 9,230 (127) -1 % 27,678 18,326 9,352 51 %
Net income attributable to common stockholders $ 152,235 $ 158,339 $ (6,104) -4 % $ 283,406 $ 471,741 $ (188,335) -40 %
(1) See Non-GAAP Financial Measures below.
The decrease in rental income is primarily attributable to the write off of straight-line rent receivables of $32,268,000 recognized during the quarter ended March 31, 2020 in conjunction with a lease amendment, the establishment of a reserve for straight-line rent receivable deemed uncollectible of $1,842,000 during the quarter ended June 30, 2020, as well as property dispositions during 2019 and 2020. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase. For the three months ended June 30, 2020, we had 9 leases with rental rate increases ranging from 0.16% to 0.36% in our Triple-net portfolio. Our Triple-net operators are experiencing similar impacts on occupancy and operating costs due to the COVID-19 pandemic as described above with respect to our Seniors Housing Operating properties. However, long-term/post-acute facilities are generally experiencing a higher degree of occupancy declines which may impact the ability of our Triple-net operators to make contractual rent payments to us in the future. Many of our Triple-net operators received funds under the CARES Act and operators of long-term/post-acute facilities have also received funds under the CARES Act Provider Relief Fund. Accordingly, collection of rent due during the COVID-19 pandemic to date (from March to July) have been consistent with historical collection rates and no significant rent concessions or deferrals have been made to date.
Depreciation and amortization fluctuates as a result of the acquisitions, dispositions and transitions of triple-net properties. To the extent we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly.
In March 2019, we recognized a provision for loan losses of $18,690,000 to fully reserve for certain real estate loans receivable that were no longer deemed collectible. During the three months ended March 31, 2020, we recognized a provision for loan losses of $6,898,000 to fully reserve for one non-real estate loan receivable that was no longer deemed collectible. During the three months ended June 30, 2020, we recognized a provision for loan losses of $1,303,00 to fully reserve for one real estate loan receivable that was no longer deemed collectible. During the three months ended March 31, 2020, we recorded impairment charges on certain held for use properties as the carrying values exceeded the estimated fair values. Changes in the
39

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
gain on sales of properties are related to the volume and timing of property sales and the sales prices. Transaction costs related to asset acquisitions are capitalized as a component of purchase price. The fluctuation in other expenses is primarily due to noncapitalizable transaction costs from acquisitions and segment transitions.
During the six months ended June 30, 2020, we completed one Triple-net construction project representing $33,627,000 or $207,574 per unit. The following is a summary of Triple-net construction projects, excluding expansions, pending as of June 30, 2020 (dollars in thousands):
Location Units/Beds Commitment Balance Est. Completion
Westerville, OH 102 $ 27,200 $ 25,092 3Q20
Thousand Oaks, CA 82 24,763 15,281 4Q20
Droitwich, UK 70 15,665 13,360 4Q20
Redhill, UK 76 19,667 9,428 2Q21
Wombourne, UK 66 14,843 3,341 2Q22
Leicester, UK 60 13,853 3,692 2Q22
456 $ 115,991 $ 70,194
The fluctuation in loss (gain) on derivatives and financial instruments, net is primarily attributable to the mark-to-market adjustment recorded on our Genesis Healthcare, Inc. available-for-sale investment. Interest expense represents secured debt interest expense and related fees. The change in secured debt interest expense is due to the net effect and timing of assumptions, segment transitions, fluctuations in foreign currency rates, extinguishments and principal amortizations. The following is a summary of our Triple-net secured debt principal activity for the periods presented (dollars in thousands):
Three Months Ended Six Months Ended
June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019
Wtd. Avg. Wtd. Avg. Wtd. Avg. Wtd. Avg.
Amount Interest Rate Amount Interest Rate Amount Interest Rate Amount Interest Rate
Beginning balance $ 289,739 3.55 % $ 292,258 3.62 % $ 306,038 3.60 % $ 288,386 3.63 %
Principal payments (1,042) 5.16 % (952) 5.25 % (2,102) 5.16 % (1,909) 5.25 %
Foreign currency 624 4.12 % (3,354) 3.21 % (14,615) 2.90 % 1,475 4.77 %
Ending balance $ 289,321 3.27 % $ 287,952 3.63 % $ 289,321 3.27 % $ 287,952 3.63 %
0.0355003165979432
Monthly averages $ 286,599 3.36 % $ 289,328 3.62 % $ 293,300 3.47 % $ 291,073 3.62 %
A portion of our Triple-net properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income relating to those partnerships where we are the controlling partner. The increase during the three months ended March 31, 2020, relates primarily to our partner's share of gains on disposal of properties.
Outpatient Medical
The following is a summary of our SSNOI at Welltower Share for the Outpatient Medical segment (dollars in thousands):
QTD Pool YTD Pool
Three Months Ended Change Six Months Ended Change
June 30, 2020 June 30, 2019 $ % June 30, 2020 June 30, 2019 $ %
SSNOI (1)
$ 79,575 $ 77,210 $ 2,365 3.1 % $ 154,897 $ 150,654 $ 4,243 2.8 %
(1) For the three and six months ended June 30, 2020 and 2019, amounts relate to 246 and 237 same store properties, respectively. Please see Non-GAAP Financial Measures for additional information and reconciliations.
40

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a summary of our results of operations for the Outpatient Medical segment for the periods presented (dollars in thousands):
Three Months Ended Change Six Months Ended Change
June 30, June 30, June 30, June 30,
2020 2019 $ % 2020 2019 $ %
Revenues:
Rental income $ 178,813 $ 163,224 $ 15,589 10 % $ 377,388 $ 312,276 $ 65,112 21 %
Interest income 461 238 223 94 % 927 411 516 126 %
Other income 1,557 (97) 1,654 n/a 1,845 139 1,706 n/a
Total revenues 180,831 163,365 17,466 11 % 380,160 312,826 67,334 22 %
Property operating expenses 51,688 50,987 701 1 % 112,296 99,153 13,143 13 %
NOI (1)
129,143 112,378 16,765 15 % 267,864 213,673 54,191 25 %
Other expenses:
Depreciation and amortization 68,070 55,445 12,625 23 % 138,403 106,454 31,949 30 %
Interest expense 4,326 3,386 940 28 % 9,134 6,734 2,400 36 %
Loss (gain) on extinguishment of debt, net 741 741 n/a 741 741 n/a
Provision for loan losses (29) (29) n/a (29) (29) n/a
Impairment of assets 10,879 (10,879) -100 % 10,879 (10,879) -100 %
Other expenses 6,456 (4) 6,460 n/a 7,463 750 6,713 n/a
79,564 69,706 9,858 14 % 155,712 124,817 30,895 25 %
Income (loss) from continuing operations before income taxes and other items
49,579 42,672 6,907 16 % 112,152 88,856 23,296 26 %
Income (loss) from unconsolidated entities 1,716 1,826 (110) -6 % 3,252 3,549 (297) -8 %
Gain (loss) on real estate dispositions, net 139,250 (2) 139,252 n/a 352,586 (7) 352,593 n/a
Income from continuing operations 190,545 44,496 146,049 328 % 467,990 92,398 375,592 406 %
Net income (loss) 190,545 44,496 146,049 328 % 467,990 92,398 375,592 406 %
Less: Net income (loss) attributable to noncontrolling interests (2,977) 812 (3,789) -467 % (524) 1,807 (2,331) -129 %
Net income (loss) attributable to common stockholders $ 193,522 $ 43,684 $ 149,838 343 % $ 468,514 $ 90,591 $ 377,923 417 %
(1) See Non-GAAP Financial Measures.
The increases in rental income are primarily attributable to acquisitions of new properties and the conversion of newly constructed outpatient medical properties, particularly the $1.25 billion CNL Healthcare Properties portfolio acquisition that closed in May 2019, partially offset by dispositions. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Our leases could renew above or below current rental rates, resulting in an increase or decrease in rental income. For the three months ended June 30, 2020, our consolidated outpatient medical portfolio signed 121,150 square feet of new leases and 353,185 square feet of renewals. The weighted-average term of these leases was six years, with a rate of $36.45 per square foot and tenant improvement and lease commission costs of $17.48 per square foot. Substantially all of these leases contain an annual fixed or contingent escalation rent structure ranging from 1.5% to 5.0%. In addition, our Outpatient Medical tenants are experiencing temporary medical practice closures or decreases in revenue due to government imposed restrictions on elective medical procedures or decisions by patients to delay treatments which may adversely effect their ability to make contractual rent payments. We have either collected or approved short term deferrals for over 99 % of rent due in the second quarter, consisting of 87% cash collections and 12 % of short term deferrals. In most cases, the deferred rent respresents two months of rent with expected repayment by the end of the year. Approximately 98% of rent due in July was either collected or aproved for short term deferral, with cash collections accelerating to approximately 95 %. Short term deferrals of July rent decreased to 3 %, which primarily relates to tenants in local jurisdictions for which relief was mandated. Furthermore, collections of deferred rent due in June and July under executed deferrals were 96 %.
The fluctuation in property operating expenses and depreciation and amortization are primarily attributable to acquisitions and construction conversions of outpatient medical facilities, offset by dispositions. To the extent that we acquire or dispose of additional properties in the future, these amounts will change accordingly. During the six months ended June 30, 2019, we recognized impairment charges related to certain held for sale properties as the carrying values exceeded the estimated fair values less costs to sell. Changes in gains/losses on sales of properties are related to volume of property sales and the sales prices. The increase in other expense during the three months ended June 30, 2020 is primarily due to noncapitalizable transaction costs from acquisitions no longer expected to be consummated.
41

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
During the six months ended June 30, 2020, we completed three Outpatient Medical construction projects representing $ 43,493,000 or $306 per square foot. The following is a summary of the Outpatient Medical construction projects, excluding expansions, pending as of June 30, 2020 (dollars in thousands):
Location Square Feet Commitment Balance Est. Completion
Brooklyn, NY 140,955 $ 105,306 $ 93,646 4Q20
Total interest expense represents secured debt interest expense. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. The following is a summary of our outpatient medical secured debt principal activity (dollars in thousands):
Three Months Ended Six Months Ended
June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019
Wtd. Ave Wtd. Ave Wtd. Ave Wtd. Ave
Amount Interest Rate Amount Interest Rate Amount Interest Rate Amount Interest Rate
Beginning balance $ 569,974 3.94 % $ 385,357 4.25 % $ 572,267 3.97 % $ 386,738 4.20 %
Debt extinguished (8,393) 4.40 % % (8,393) 4.40 % %
Principal payments (2,538) 4.61 % (1,507) 5.02 % (4,831) 4.63 % (2,888) 5.06 %
Ending balance $ 559,043 3.59 % $ 383,850 4.22 % $ 559,043 3.59 % $ 383,850 4.22 %
Monthly averages $ 566,608 3.75 % $ 384,603 4.24 % $ 568,751 3.85 % $ 386,088 4.24 %
A portion of our Outpatient Medical properties were formed through partnerships. Income or loss from unconsolidated entities represents our share of net income or losses from partnerships where we are the noncontrolling partner. Net income attributable to noncontrolling interests represents our partners’ share of net income or loss relating to those partnerships where we are the controlling partner.
Non-Segment/Corporate
The following is a summary of our results of operations for the Non-Segment/Corporate activities for the periods presented (dollars in thousands):
Three Months Ended Change Six Months Ended Change
June 30, June 30, June 30, June 30,
2020 2019 $ % 2020 2019 $ %
Revenues:
Other income
$ 375 $ 454 $ (79) -17 % $ 791 $ 2,611 $ (1,820) -70 %
Total revenue
375 454 (79) -17 % 791 2,611 (1,820) -70 %
Expenses:
Interest expense
105,256 117,153 (11,897) -10 % 223,169 237,346 (14,177) -6 %
General and administrative expenses
34,062 33,741 321 1 % 69,543 69,023 520 1 %
Loss (gain) on extinguishment of debt, net
n/a 15,719 (15,719) -100 %
Other expenses
4,204 4,215 (11) % 5,987 6,242 (255) -4 %
143,522 155,109 (11,587) -7 % 298,699 328,330 (29,631) -9 %
Loss from continuing operations before
income taxes and other items
(143,147) (154,655) 11,508 7 % (297,908) (325,719) 27,811 9 %
Income tax (expense) benefit (2,233) (1,599) (634) -40 % (7,675) (3,821) (3,854) -101 %
Loss from continuing operations (145,380) (156,254) 10,874 7 % (305,583) (329,540) 23,957 7 %
Net loss attributable to common stockholders $ (145,380) $ (156,254) $ 10,874 7 % $ (305,583) $ (329,540) $ 23,957 7 %
The following is a summary of our Non-Segment/Corporate interest expense or the periods presented (dollars in thousands):
Three Months Ended Change Six Months Ended Change
June 30, June 30, June 30, June 30,
2020 2019 $ % 2020 2019 $ %
Senior unsecured notes $ 98,141 $ 98,475 $ (334) % $ 201,675 $ 207,231 $ (5,556) -3 %
Unsecured credit facility and commercial paper program 2,816 15,160 (12,344) -81 % 12,984 22,678 (9,694) -43 %
Loan expense 4,299 3,518 781 22 % 8,510 7,437 1,073 14 %
Totals $ 105,256 $ 117,153 $ (11,897) -10 % $ 223,169 $ 237,346 $ (14,177) -6 %
42

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The change in interest expense on senior unsecured notes is due to the net effect of issuances and extinguishments, as well as the movement in foreign exchange rates and related hedge activity. Please refer to Note 11 for additional information. The change in interest expense on our unsecured revolving credit facility and commercial paper program is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes. Please refer to Note 10 for additional information regarding our unsecured revolving credit facility and commercial paper program. The loss on extinguishment recognized during the six months ended June 30, 2019 is due to the early extinguishment of the $600,000,000 of 4.125% senior unsecured notes due 2019 and the $450,000,000 of 6.125% senior unsecured notes due 2020.
General and administrative expenses as a percentage of consolidated revenues for the three months ended June 30, 2020 and 2019 were 2.87% and 2.56%, respectively. The provision for income taxes primarily relates to state taxes, foreign taxes and taxes based on income generated by entities that are structured as TRSs.
Non-GAAP Financial Measures
We believe that net income and net income attributable to common stockholders (“NICS”), as defined by U.S. GAAP, are the most appropriate earnings measurements. However, we consider FFO, NOI, SSNOI, EBITDA and Adjusted EBITDA to be useful supplemental measures of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created funds from operations attributable to common stockholders (“FFO”) as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means NICS, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate and impairment of depreciable assets, plus depreciation and amortization, and after adjustments for unconsolidated entities and noncontrolling interests.
Consolidated net operating income (“NOI”) is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property operating expenses. Property operating expenses represent costs associated with managing, maintaining and servicing tenants for our properties. These expenses include, but are not limited to, property-related payroll and benefits, property management fees paid to operators, marketing, housekeeping, food service, maintenance, utilities, property taxes and insurance. General and administrative expenses represent costs unrelated to property operations. These expenses include, but are not limited to, payroll and benefits, professional services, office expenses and depreciation of corporate fixed assets. Same store NOI (“SSNOI”) is used to evaluate the operating performance of our properties using a consistent population which controls for changes in the composition of our portfolio. We believe the drivers of property level NOI for both consolidated properties and unconsolidated properties are generally the same and therefore, we evaluate SSNOI based on our ownership interest in each property ("Welltower Share"). To arrive at Welltower's Share, NOI is adjusted by adding our minority ownership share related to unconsolidated properties and by subtracting the minority partners' noncontrolling ownership interests for consolidated properties. We do not control investments in unconsolidated properties and while we consider disclosures at Welltower Share to be useful, they may not accurately depict the legal and economic implications of our joint venture arrangements and should be used with caution. As used herein, same store is generally defined as those revenue-generating properties in the portfolio for the relevant year-over-year reporting periods. Acquisitions and development conversions are included in SSNOI five full quarters or six full quarters after acquisition or being placed into service for the QTD Pool and the YTD Pool, respectively. Land parcels, loans and sub-leases, as well as any properties sold or classified as held for sale during the respective periods are excluded from SSNOI. Redeveloped properties (including major refurbishments of a Seniors Housing Operating property where 20% or more of units are simultaneously taken out of commission for 30 days or more or Outpatient Medical properties undergoing a change in intended use) are excluded from SSNOI until five full quarters or six full quarters post completion of the redevelopment for the QTD Pool and YTD Pool, respectively. Properties undergoing operator transitions and/or segment transitions are also excluded from SSNOI until five full quarters or six full quarters post completion of the transition for the QTD Pool and YTD Pool, respectively. In addition, properties significantly impacted by force majeure, acts of God, or other extraordinary adverse events are excluded from SSNOI until five full quarters or six full quarters after the properties are placed back into service for the QTD Pool and YTD Pool, respectively. SSNOI excludes non-cash NOI and includes adjustments to present consistent ownership percentages and to translate Canadian properties and UK properties using a consistent exchange rate. We believe NOI and SSNOI provide investors relevant and useful information because they measure the operating performance of our properties at the property level on an unleveraged basis. We use NOI and SSNOI to make decisions about resource allocations and to assess the property level performance of our properties.
EBITDA stands for earnings (net income) before interest, taxes, depreciation and amortization. We believe that EBITDA, along with net income and cash flow provided from operating activities, is an important supplemental measure because it provides additional information to assess and evaluate the performance of our operations. We primarily utilize EBITDA to
43

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
measure our interest coverage ratio, which represents EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA divided by fixed charges. Fixed charges include total interest and secured debt principal amortization. Covenants in our senior unsecured notes and primary unsecured credit facility contain financial ratios based on a definition of EBITDA that is specific to those agreements. Failure to satisfy these covenants could result in an event of default that could have a material adverse impact on our cost and availability of capital, which could in turn, have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Due to the materiality of these debt agreements and the financial covenants, we have disclosed Adjusted EBITDA, which represents EBITDA as defined above excluding unconsolidated entities and adjusted for items per our covenant. We use Adjusted EBITDA to measure our adjusted fixed charge coverage ratio, which represents Adjusted EBITDA divided by fixed charges on a trailing twelve months basis. Fixed charges include total interest (excluding capitalized interest and non-cash interest expenses), secured debt principal amortization and preferred dividends. Our covenant requires an adjusted fixed charge coverage ratio of at least 1.50 times.
Our supplemental reporting measures and similarly entitled financial measures are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.
Three Months Ended
June 30, March 31, December 31, September 30, June 30, March 31,
NOI Reconciliations: 2020 2020 2019 2019 2019 2019
Net income (loss) $ 159,216 $ 329,380 $ 240,136 $ 647,932 $ 150,040 $ 292,302
Loss (gain) on real estate dispositions, net (155,863) (262,824) (12,064) (570,250) 1,682 (167,409)
Loss (income) from unconsolidated entities (1,332) 3,692 (57,420) (3,262) 9,049 9,199
Income tax expense (benefit) 2,233 5,442 (4,832) 3,968 1,599 2,222
Other expenses 19,411 6,292 16,042 6,186 21,628 8,756
Impairment of assets 75,151 27,827 98 18,096 9,939
Provision for loan losses 1,422 7,072 18,690
Loss (gain) on extinguishment of debt, net 249 2,612 65,824 15,719
Loss (gain) on derivatives and financial instruments, net 1,434 7,651 (5,069) 1,244 1,913 (2,487)
General and administrative expenses 34,062 35,481 26,507 31,019 33,741 35,282
Depreciation and amortization 265,371 274,801 262,644 272,445 248,052 243,932
Interest expense 126,357 142,007 131,648 137,343 141,336 145,232
Consolidated net operating income (NOI) $ 527,711 $ 576,821 $ 600,302 $ 610,545 $ 618,979 $ 601,438
NOI by segment:
Seniors Housing Operating $ 178,137 $ 243,257 $ 242,453 $ 254,155 $ 278,212 $ 264,700
Triple-net 220,056 194,427 226,837 230,685 227,935 233,286
Outpatient Medical 129,143 138,721 130,498 124,864 112,378 101,295
Non-segment/corporate 375 416 514 841 454 2,157
Total NOI $ 527,711 $ 576,821 $ 600,302 $ 610,545 $ 618,979 $ 601,438

44

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Six Months Ended
June 30, 2020 June 30, 2019
NOI Reconciliations:
Net income (loss) $ 488,596 $ 442,342
Loss (gain) on real estate dispositions, net (418,687) (165,727)
Loss (income) from unconsolidated entities 2,360 18,248
Income tax expense (benefit) 7,675 3,821
Other expenses 25,703 30,384
Impairment of assets 102,978 9,939
Provision for loan losses 8,494 18,690
Loss (gain) on extinguishment of debt, net 249 15,719
Loss (gain) on derivatives and financial instruments, net 9,085 (574)
General and administrative expenses 69,543 69,023
Depreciation and amortization 540,172 491,984
Interest expense 268,364 286,568
Consolidated net operating income (NOI) $ 1,104,532 $ 1,220,417
NOI by segment:
Seniors Housing Operating $ 421,394 $ 542,912
Triple-net 414,483 461,221
Outpatient Medical 267,864 213,673
Non-segment/corporate 791 2,611
Total NOI $ 1,104,532 $ 1,220,417

QTD Pool YTD Pool
Three Months Ended Six Months Ended
SSNOI Reconciliations: June 30, 2020 June 30, 2019 June 30, 2020 June 30, 2019
Seniors Housing Operating:
Consolidated NOI
$ 178,137 $ 278,212 $ 421,394 $ 542,912
NOI attributable to unconsolidated investments
14,954 16,439 28,231 32,462
NOI attributable to noncontrolling interests
(13,547) (22,167) (30,624) (41,869)
NOI attributable to non-same store properties
(15,796) (53,994) (79,900) (131,368)
Non-cash NOI attributable to same store properties
(959) (82) (1,834) 457
Currency and ownership adjustments (1)
1,133 (846) (609) (1,453)
SSNOI at Welltower Share 163,922 217,562 336,658 401,141
Triple-net:
Consolidated NOI
220,056 227,935 414,483 461,221
NOI attributable to unconsolidated investments
5,133 5,078 10,266 10,266
NOI attributable to noncontrolling interests
(14,613) (14,435) (29,396) (29,136)
NOI attributable to non-same store properties
(28,722) (32,954) (56,524) (76,160)
Non-cash NOI attributable to same store properties
(12,132) (16,074) 789 (31,347)
Currency and ownership adjustments (1)
1,061 234 1,152 84
SSNOI at Welltower Share 170,783 169,784 340,770 334,928
Outpatient Medical:
Consolidated NOI
129,143 112,378 267,864 213,673
NOI attributable to unconsolidated investments
1,063 310 3,524 617
NOI attributable to noncontrolling interests
(2,366) (6,139) (8,366) (13,128)
NOI attributable to non-same store properties
(47,581) (21,077) (97,787) (32,485)
Non-cash NOI attributable to same store properties
(1,057) (1,903) (2,791) (3,892)
Currency and ownership adjustments (1)
373 (6,359) (7,547) (14,131)
SSNOI at Welltower Share 79,575 77,210 154,897 150,654
SSNOI at Welltower Share:
Seniors Housing Operating
163,922 217,562 336,658 401,141
Triple-net
170,783 169,784 340,770 334,928
Outpatient Medical
79,575 77,210 154,897 150,654
Total $ 414,280 $ 464,556 $ 832,325 $ 886,723
(1) Includes adjustments to reflect consistent property ownership percentages, to translate Canadian properties at a USD/CAD rate of 1.32 and to translate UK properties at a GBP/USD rate of 1.30.

45

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations


QTD Pool YTD Pool
SSNOI Property Reconciliations: Seniors Housing Operating Triple-net Outpatient Medical Total Seniors Housing Operating Triple-net Outpatient Medical Total
Consolidated properties
526 653 347 1,526 526 653 347 1,526
Unconsolidated properties
86 39 36 161 86 39 36 161
Total properties
612 692 383 1,687 612 692 383 1,687
Recent acquisitions/development conversions (1)
(34) (8) (113) (155) (71) (11) (122) (204)
Under development
(23) (6) (1) (30) (23) (6) (1) (30)
Under redevelopment (2)
(10) (1) (2) (13) (11) (1) (2) (14)
Current held for sale
(7) (3) (13) (23) (7) (3) (13) (23)
Land parcels, loans and subleases
(10) (17) (8) (35) (10) (17) (8) (35)
Transitions (3)
(31) (16) (47) (73) (19) (92)
Other
(1) (1)
Same store properties
497 641 246 1,384 416 635 237 1,288
(1) Acquisitions and development conversions will enter the QTD Pool and YTD Pool five full quarters and six full quarters after acquisition or certificate of occupancy, respectively.
(2) Redevelopment properties will enter the QTD Pool and YTD Pool after five full quarters and six full quarters of operations post redevelopment completion, respectively.
(3) Transitioned properties will enter the QTD Pool and YTD Pool after five full quarters and six full quarter of operations with the new operator in place or under the new structure, respectively.
The table below reflects the reconciliation of FFO to NICS, the most directly comparable U.S. GAAP measure, for the periods presented. Noncontrolling interest and unconsolidated entity amounts represent adjustments to reflect our share of depreciation and amortization, gains/loss on real estate dispositions and impairment of assets. Amounts are in thousands except for per share data.
Three Months Ended
June 30, March 31, December 31, September 30, June 30, March 31,
FFO Reconciliation: 2020 2020 2019 2019 2019 2019
Net income attributable to common stockholders $ 179,246 $ 310,284 $ 224,324 $ 589,876 $ 137,762 $ 280,470
Depreciation and amortization 265,371 274,801 262,644 272,445 248,052 243,932
Impairment of assets 75,151 27,827 98 18,096 9,939
Loss (gain) on real estate dispositions, net (155,863) (262,824) (12,064) (570,250) 1,682 (167,409)
Noncontrolling interests (42,539) (9,409) (14,895) 31,347 (18,889) (17,760)
Unconsolidated entities 14,231 15,445 16,191 10,864 11,475 19,150
FFO $ 335,597 $ 356,124 $ 476,298 $ 352,378 $ 390,021 $ 358,383
Average diluted shares outstanding 419,121 412,420 407,904 406,891 406,673 393,452
Per diluted share data:
Net income attributable to common stockholders (1)
$ 0.42 $ 0.75 $ 0.55 $ 1.45 $ 0.34 $ 0.71
FFO
$ 0.80 $ 0.86 $ 1.17 $ 0.87 $ 0.96 $ 0.91
(1) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.

46

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Six Months Ended
June 30, June 30,
FFO Reconciliations: 2020 2019
Net income attributable to common stockholders $ 489,530 $ 418,232
Depreciation and amortization 540,172 491,984
Impairment of assets 102,978 9,939
Loss (gain) on real estate dispositions, net (418,687) (165,727)
Noncontrolling interests (51,948) (36,649)
Unconsolidated entities 29,676 30,625
FFO $ 691,721 $ 748,404
Average diluted common shares outstanding: 415,775 400,096
Per diluted share data:
Net income attributable to common stockholders (1)
$ 1.17 $ 1.05
FFO
$ 1.66 $ 1.87
(1) Includes adjustment to the numerator for income (loss) attributable to OP unitholders.

The tables below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.
Three Months Ended
June 30, March 31, December 31, September 30, June 30, March 31,
EBITDA Reconciliations: 2020 2020 2019 2019 2019 2019
Net income (loss) $ 159,216 $ 329,380 $ 240,136 $ 647,932 $ 150,040 $ 292,302
Interest expense 126,357 142,007 131,648 137,343 141,336 145,232
Income tax expense (benefit) 2,233 5,442 (4,832) 3,968 1,599 2,222
Depreciation and amortization 265,371 274,801 262,644 272,445 248,052 243,932
EBITDA $ 553,177 $ 751,630 $ 629,596 $ 1,061,688 $ 541,027 $ 683,688
Interest Coverage Ratio:
Interest expense $ 126,357 $ 142,007 $ 131,648 $ 137,343 $ 141,336 $ 145,232
Non-cash interest expense (1,914) (8,125) (734) (1,988) (752) (5,171)
Capitalized interest 4,541 4,746 4,868 4,148 3,929 2,327
Total interest
128,984 138,628 135,782 139,503 144,513 142,388
EBITDA $ 553,177 $ 751,630 $ 629,596 $ 1,061,688 $ 541,027 $ 683,688
Interest coverage ratio
4.29 x 5.42 x 4.64 x 7.61 x 3.74 x 4.80 x
Fixed Charge Coverage Ratio:
Total interest $ 128,984 $ 138,628 $ 135,782 $ 139,503 $ 144,513 $ 142,388
Secured debt principal payments 15,183 15,526 13,977 13,121 13,684 13,543
Total fixed charges
144,167 154,154 149,759 152,624 158,197 155,931
EBITDA $ 553,177 $ 751,630 $ 629,596 $ 1,061,688 $ 541,027 $ 683,688
Fixed charge coverage ratio
3.84 x 4.88 x 4.20 x 6.96 x 3.42 x 4.38 x


47

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Six Months Ended
June 30, June 30,
EBITDA Reconciliations: 2020 2019
Net income (loss) $ 488,596 $ 442,342
Interest expense 268,364 286,568
Income tax expense (benefit) 7,675 3,821
Depreciation and amortization 540,172 491,984
EBITDA $ 1,304,807 $ 1,224,715
Interest Coverage Ratio:
Interest expense $ 268,364 $ 286,568
Non-cash interest expense (10,039) (5,923)
Capitalized interest 9,287 6,256
Total interest
267,612 286,901
EBITDA $ 1,304,807 $ 1,224,715
Interest coverage ratio
4.88 x 4.27 x
Fixed Charge Coverage Ratio:
Total interest $ 267,612 $ 286,901
Secured debt principal payments 30,709 27,227
Total fixed charges
298,321 314,128
EBITDA $ 1,304,807 $ 1,224,715
Fixed charge coverage ratio
4.37 x 3.90 x



48

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Dollars are in thousands.
Twelve Months Ended
June 30, March 31, December 31, September 30, June 30, March 31,
Adjusted EBITDA Reconciliations: 2020 2020 2019 2019 2019 2019
Net income $ 1,376,664 $ 1,367,488 $ 1,330,410 $ 1,214,970 $ 651,264 $ 668,497
Interest expense 537,355 552,334 555,559 568,280 568,969 549,049
Income tax expense (benefit) 6,811 6,177 2,957 9,293 7,066 9,308
Depreciation and amortization 1,075,261 1,057,942 1,027,073 1,007,263 977,967 966,190
EBITDA
2,996,091 2,983,941 2,915,999 2,799,806 2,205,266 2,193,044
Loss (income) from unconsolidated entities (58,322) (47,941) (42,434) 14,791 17,709 7,411
Stock-based compensation expense (1)
24,229 24,601 25,047 25,347 26,113 23,618
Loss (gain) on extinguishment of debt, net 68,685 68,436 84,155 81,596 19,810 20,109
Loss (gain) on real estate dispositions, net (1,001,001) (843,456) (748,041) (777,890) (232,363) (244,800)
Impairment of assets 121,172 55,960 28,133 104,057 92,701 87,394
Provision for loan losses 8,494 7,072 18,690 18,690 18,690 18,690
Loss (gain) on derivatives and financial instruments, net 5,260 5,739 (4,399) 2,296 10,043 670
Other expenses (1)
46,971 48,327 51,052 45,512 126,994 117,942
Other impairment (2)
34,110 32,268
Additional other income (4,027) (4,027) (14,832)
Adjusted EBITDA $ 2,245,689 $ 2,334,947 $ 2,328,202 $ 2,310,178 $ 2,280,936 $ 2,209,246
Adjusted Interest Coverage Ratio:
Interest expense $ 537,355 $ 552,334 $ 555,559 $ 568,280 $ 568,969 $ 549,049
Capitalized interest 18,303 17,691 15,272 11,952 9,725 7,896
Non-cash interest expense (12,761) (11,599) (8,645) (11,218) (10,888) (11,852)
Total interest
542,897 558,426 562,186 569,014 567,806 545,093
Adjusted EBITDA $ 2,245,689 $ 2,334,947 $ 2,328,202 $ 2,310,178 $ 2,280,936 $ 2,209,246
Adjusted interest coverage ratio
4.14 x 4.18 x 4.14 x 4.06 x 4.02 x 4.05 x
Adjusted Fixed Charge Coverage Ratio:
Total interest $ 542,897 $ 558,426 $ 562,186 $ 569,014 $ 567,806 $ 545,093
Secured debt principal payments 57,807 56,308 54,325 54,342 55,129 55,584
Preferred dividends 11,676 23,352 35,028
Total fixed charges
600,704 614,734 616,511 635,032 646,287 635,705
Adjusted EBITDA $ 2,245,689 $ 2,334,947 $ 2,328,202 $ 2,310,178 $ 2,280,936 $ 2,209,246
Adjusted fixed charge coverage ratio
3.74 x 3.80 x 3.78 x 3.64 x 3.53 x 3.48 x
(1) Certain severance-related costs are included in stock-based compensation and excluded from other expenses.
(2) Represents straight-line recent receivable deemed uncollectible.

Our leverage ratios include book capitalization, undepreciated book capitalization and market capitalization. Book capitalization represents the sum of net debt (defined as total long-term debt less cash and cash equivalents and any IRC section 1031 deposits), total equity and redeemable noncontrolling interests. Undepreciated book capitalization represents book capitalization adjusted for accumulated depreciation and amortization. Market capitalization represents book capitalization adjusted for the fair market value of our common stock. Our leverage ratios are defined as the proportion of net debt to total capitalization. The table below reflects the reconciliation of our leverage ratios to our balance sheets for the periods presented. Amounts are in thousands, except share price.
49

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
As of
June 30, March 31, December 31, September 30, June 30, March 31,
2020 2020 2019 2019 2019 2019
Book capitalization:
Unsecured credit facility and commercial paper $ $ 844,985 $ 1,587,597 $ 1,334,586 $ 1,869,188 $ 419,293
Long-term debt obligations (1)
14,543,485 13,228,433 13,436,365 12,463,680 13,390,344 12,371,729
Cash and cash equivalents (2)
(1,766,819) (303,423) (284,917) (265,788) (268,666) (249,127)
Total net debt 12,776,666 13,769,995 14,739,045 13,532,478 14,990,866 12,541,895
Total equity and noncontrolling interests (3)
17,263,672 17,495,696 16,982,504 16,696,070 16,452,806 16,498,376
Book capitalization $ 30,040,338 $ 31,265,691 $ 31,721,549 $ 30,228,548 $ 31,443,672 $ 29,040,271
Net debt to book capitalization ratio
43 % 44 % 46 % 45 % 48 % 43 %
Undepreciated book capitalization:
Total net debt $ 12,776,666 $ 13,769,995 $ 14,739,045 $ 13,532,478 $ 14,990,866 $ 12,541,895
Accumulated depreciation and amortization 6,001,177 5,910,979 5,715,459 5,769,843 5,539,435 5,670,111
Total equity and noncontrolling interests (3)
17,263,672 17,495,696 16,982,504 16,696,070 16,452,806 16,498,376
Undepreciated book capitalization $ 36,041,515 $ 37,176,670 $ 37,437,008 $ 35,998,391 $ 36,983,107 $ 34,710,382
Net debt to undepreciated book
capitalization ratio
35 % 37 % 39 % 38 % 41 % 36 %
Market capitalization:
Common shares outstanding 417,302 417,391 410,257 405,758 405,254 403,740
Period end share price $ 51.75 $ 45.78 $ 81.78 $ 90.65 $ 81.53 $ 77.6
Common equity market capitalization $ 21,595,379 $ 19,108,160 $ 33,550,817 $ 36,781,963 $ 33,040,359 $ 31,330,224
Total net debt 12,776,666 13,769,995 14,739,045 13,532,478 14,990,866 12,541,895
Noncontrolling interests (3)
1,215,532 1,362,913 1,442,060 1,430,005 1,458,351 1,419,885
Market capitalization $ 35,587,577 $ 34,241,068 $ 49,731,922 $ 51,744,446 $ 49,489,576 $ 45,292,004
Net debt to market capitalization ratio
36 % 40 % 30 % 26 % 30 % 28 %
(1) Amounts include senior unsecured notes, secured debt and lease liabilities related to financing leases, as reflected on our Consolidated Balance Sheet. Operating lease liabilities related to the ASC 842 adoption are excluded.
(2) Inclusive of IRC section 1031 deposits, if any.
(3) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests as reflected on our Consolidated Balance Sheet.

Critical Accounting Policies
Our unaudited consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions. Management considers an accounting estimate or assumption critical if:
the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and
the impact of the estimates and assumptions on financial condition or operating performance is material.
Management has discussed the development and selection of its critical accounting policies with the Audit Committee of the Board of Directors. Management believes the current assumptions and other considerations used to estimate amounts reflected in our unaudited consolidated financial statements are appropriate and are not reasonably likely to change in the future. However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our unaudited consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition. Please refer to Note 2 to the financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 for further information regarding significant accounting policies that impact us. There have been no material changes to these policies in 2020, except the adoption of ASC 2016-13. See Notes 2 and 7 to the unaudited consolidated financial statements for details.
50

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Cautionary Statement Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q may contain “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. When Welltower uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “pro forma,” “estimate” or similar expressions that do not relate solely to historical matters, Welltower is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause Welltower’s actual results to differ materially from Welltower’s expectations discussed in the forward-looking statements. This may be a result of various factors, including, but not limited to: the duration and scope of the COVID-19 pandemic; the impact of the COVID-19 pandemic on occupancy rates and on the operations of Welltower and its operators/tenants; actions governments take in response to the COVID-19 pandemic, including the introduction of public health measures and other regulations affecting Welltower’s properties and the operations of Welltower and its operators/tenants; the effects of health and safety measures adopted by Welltower and its operators/tenants related to the COVID-19 pandemic; increased operational costs as a result of health and safety measures related to COVID-19; the impact of the COVID-19 pandemic on the business and financial condition of operators/tenants and their ability to make payments to Welltower; disruptions to Welltower's property acquisition and disposition activity due to economic uncertainty caused by COVID-19; general economic uncertainty in key markets as a result of the COVID-19 pandemic and a worsening of global economic conditions or low levels of economic growth; the status of capital markets, including availability and cost of capital; uncertainty from the expected discontinuance of LIBOR and the transition to any other interest rate benchmark; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies, responding to government investigations and punitive settlements and operators’/tenants’ difficulty in cost effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and seniors housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; Welltower’s ability to transition or sell properties with profitable results; the failure to make new investments or acquisitions as and when anticipated; natural disasters and other acts of God affecting Welltower’s properties; Welltower’s ability to re-lease space at similar rates as vacancies occur; Welltower’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant or joint venture partner bankruptcies or insolvencies; the cooperation of joint venture partners; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future investments or acquisitions; environmental laws affecting Welltower’s properties; changes in rules or practices governing Welltower’s financial reporting; the movement of U.S. and foreign currency exchange rates; Welltower’s ability to maintain Welltower’s qualification as a REIT; key management personnel recruitment and retention; and other risks described in Welltower’s reports filed from time to time with the SEC. Other important factors are identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise, or to update the reasons why actual results could differ from those projected in any forward-looking statements.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates and foreign currency exchange rates. We seek to mitigate the underlying foreign currency exposures with gains and losses on derivative contracts hedging these exposures. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates and foreign currency exchange rates.
We historically borrow on our unsecured revolving credit facility and commercial paper program to acquire, construct or make loans relating to health care and seniors housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under our unsecured revolving credit facility and commercial paper program. We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.

51

Item 3. Quantitative and Qualitative Disclosures About Market Risk
A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments’ change in fair value. The following table summarizes the analysis performed as of the dates indicated (in thousands):
June 30, 2020 December 31, 2019
Principal Change in Principal Change in
balance fair value balance fair value
Senior unsecured notes $ 10,219,090 $ (734,201) $ 9,724,691 $ (751,848)
Secured debt 1,703,145 (60,928) 1,814,229 (69,756)
Totals $ 11,922,235 $ (795,129) $ 11,538,920 $ (821,604)
Our variable rate debt, including our unsecured revolving credit facility and commercial paper program, is reflected at fair value. At June 30, 2020, we had $2,618,465,000 outstanding related to our variable rate debt. Assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $26,185,000. At December 31, 2019, we had $3,470,584,000 outstanding under our variable rate debt. Assuming no changes in outstan ding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $34,706,000.
We are subject to currency fluctuations that may, from time to time, affect our financial condition and results of operations. Increases or decreases in the value of the Canadian Dollar or British Pounds Sterling relative to the U.S. Dollar impact the amount of net income we earn from our investments in Canada and the United Kingdom. Based solely on our results for the three months ended June 30, 2020, including the impact of existing hedging arrangements, if these exchange rates were to increase or decrease by 10%, our net income from these investments would increase or decrease, as applicable, by less than $6,000,000. We will continue to mitigate these underlying foreign currency exposures with non-U.S. denominated borrowings and gains and losses on derivative contracts. If we increase our international presence through investments in, or acquisitions or development of, seniors housing and health care properties outside the U.S., we may also decide to transact additional business or borrow funds in currencies other than U.S. Dollars, Canadian Dollars or British Pounds Sterling. To illustrate the impact of changes in foreign currency markets, we performed a sensitivity analysis on our derivative portfolio whereby we modeled the change in net present values arising from a hypothetical 1% increase in foreign currency exchange rates to determine the instruments’ change in fair value. The following table summarizes the results of the analysis performed (dollars in thousands):
June 30, 2020 December 31, 2019
Carrying Change in Carrying Change in
Value fair value Value fair value
Foreign currency forward contracts $ 163,527 $ 11,194 $ 26,767 $ 12,136
Debt designated as hedges 1,482,366 14,824 1,586,116 15,861
Totals $ 1,645,893 $ 26,018 $ 1,612,883 $ 27,997
For additional information regarding fair values of financial instruments, see “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies” and Notes 12 and 17 to our unaudited consolidated financial statements.
Item 4. Controls and Procedures
Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the SEC under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. No changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
52


PART II. OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, there are various legal proceedings pending against us that arise in the ordinary course of our business. Management does not believe that the resolution of any of these legal proceedings either individually or in the aggregate will have a material adverse effect on our business, results of operations or financial condition. Further, from time to time, we are party to certain legal proceedings for which third parties, such as tenants, operators and/or managers are contractually obligated to indemnify, defend and hold us harmless. In some of these matters, the indemnitors have insurance for the potential damages. In other matters, we are being defended by tenants and other obligated third parties and these indemnitors may not have sufficient insurance, assets, income or resources to satisfy their defense and indemnification obligations to us. The unfavorable resolution of such legal proceedings could, individually or in the aggregate, materially adversely affect the indemnitors’ ability to satisfy their respective obligations to us, which, in turn, could have a material adverse effect on our business, results of operations or financial condition. It is management’s opinion that there are currently no such legal proceedings pending that will, individually or in the aggregate, have such a material adverse effect. Despite management’s view of the ultimate resolution of these legal proceedings, we may have significant legal expenses and costs associated with the defense of such matters. Further, management cannot predict the outcome of these legal proceedings and if management’s expectation regarding such matters is not correct, such proceedings could have a material adverse effect on our business, results of operations or financial condition.
Item 1A. Risk Factors
There have been no material changes from the risk factors identified under the heading "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019 and updated in our Quarterly Report on Form 10-Q for the period ending March 31, 2020.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the three months ended June 30, 2020 , we acquired shares of our common stock held by employees who tendered shares to satisfy tax withholding obligations upon the vesting of previously issued restricted stock awards. Specifically, the number of shares of common stock acquired from employees and the average prices paid per share for each month in the second quarter ended June 30, 2020 are as shown in the table below.
On May 1, 2020, our Board of Directors authorized a share repurchase program whereby we may repurchase up to $1 billion of common stock through December 31, 2021 (the "Repurchase Program"). Under this authorization, we are not required to purchase shares but may choose to do so in the open market or through private transactions at times and amounts based on our evaluation of market conditions and other factors. We expect to finance any share repurchases under the Repurchase Program using available cash and may use proceeds from borrowings or debt offerings. During the three months ended June 30, 2020, we repurchased 201,947 shares at an average price of $37.89 per share.
Issuer Purchases of Equity Securities
Period Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Repurchase Program Maximum Dollar Value of Shares that May Yet Be Purchased Under the Repurchase Program
April 1, 2020 through April 30, 2020 286 $ 49.01 $
May 1, 2020 through May 31, 2020 201,947 37.89 201,947 992,348,000
June 1, 2020 through June 30, 2020
Totals 202,233 $ 37.91 201,947 $ 992,348,000
.
Item 5. Other Information
None.

53


Item 6. Exhibits
4.1 Supplemental Indenture No. 18, dated as of June 30, 2020, between the Company and the Trustee (incorporated by reference to Exhibit 4.2 to Form 8-K filed on June 30, 2020).
31.1
31.2
32.1
32.2
101.INS XBRL Instance Document. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
104 The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, formatted in Inline XBRL
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
WELLTOWER INC.
Date: August 6, 2020 By: /s/ THOMAS J. DEROSA
Thomas J. DeRosa,
Chairman and Chief Executive Officer
(Principal Executive Officer)
Date: August 6, 2020 By: /s/ TIMOTHY G. MCHUGH
Timothy G. McHugh,
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
Date: August 6, 2020 By: /s/ JOSHUA T. FIEWEGER
Joshua T. Fieweger,
Senior Vice President and Controller
(Principal Accounting Officer)
54
TABLE OF CONTENTS